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Abstract
Acute rheumatic fever is a major cause of heart disease in many parts of the
world. Though it is generally considered rare in developed countries, is remains
a large issue in New Zealand. Of particular concern is the prevalence of acute
rheumatic fever among Maori and Pacific Island peoples. In this thesis we develop
a model to simulate acute rheumatic fever in a population. We discuss the use of
both deterministic methods and stochastic processes. Demographics and statistics
specific to New Zealand are then used to develop the model in a way that fits
specifically to the situation in New Zealand. We also consider the introduction of
treatment strategies for acute rheumatic fever and discuss how risk factors can be
used to focus such strategies.
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Chapter 1
Introduction
Acute rheumatic fever is an autoimmune response to an infection by Group A
Streptococcus. This means the immune system creates antibodies in response to
the infection, but as well as attacking the infecting bacteria, certain body tissues
are also damaged. Tissue such as cardiac tissue, joints, skin, and the central
nervous system are affected in particular [11]. Repeat attacks of acute rheumatic
fever can lead to chronic rheumatic heart disease and permanent damage to the
heart valves [18].
Internationally acute rheumatic fever is considered rare in developed countries [31],
but is still acknowledged as highly prevalent in developing countries [11]. Up until
the late 1980’s its eradication in western developed countries was considered a very
real possibility. The decline of acute rheumatic fever, however was halted by the
reappearance of isolated out-breaks in the United States [1].
Acute rheumatic fever is a significant problem in New Zealand, particularly among
Maori and Pacifica peoples between the ages of 5 and 45. New Zealand maintains
some of the highest rates of acute rheumatic fever in a developed country. The
respective rates for Maori and Pacific Islanders equate to those of many developing
countries.[18].
We can use mathematical models as a way of estimating how different rates of
infection, individual interaction and treatment programs might affect the spread of
a disease. In using mathematical models we can save time, as we can plot estimates
1
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for different scenarios much more quickly than the the time disease might actually
take to run its course in the population. They also allow us to overcome some of
the obvious ethical issues surrounding experimenting with diseases.
In this thesis I provide a background in mathematical modelling of infectious dis-
eases and how these models might apply to acute rheumatic fever. I also develop
a model in stages, that can follow the behaviour of acute rheumatic fever in New
Zealand and account for the different factors that are specific to this popula-
tion. I then discuss how this kind of model could be useful in developing realistic
treatment programs and reducing the incidence of acute rheumatic fever in New
Zealand.
Chapter 2
Infectious Disease Modelling
Mathematical modelling in epidemiology provides an understanding of the under-
lying mechanisms involved in the spread of a disease that may often be missed
in an analysis of experimental data. Models can also help us suggest appropriate
control strategies. For endemic diseases the possibility of controlling or even erad-
icating a disease that has been persistent in the population is worthy of study.
[7].
Mathematical modelling of biological systems, including epidemics, is often suc-
cessfully attacked in steps, starting simply and adding complexity as needed to
better model real data [7]. In an epidemiological model we aim to answer several
questions about the possible severity of the epidemic. We want to know the total
number of individuals who would be affected and how many could need care at
any point in time. Other details such as how long the epidemic might last and
how much good quarantine would do are also of interest.
There is always a tradeoff between simplicity and detail. Simple models are of
value as they are often the building blocks of more complicated models. They
can also be useful in highlighting general qualitative behaviour. More detailed
models are often designed for specific situations. They are generally difficult to
solve analytically however, which limits how useful they can be. Focusing on the
asymptotic behaviour of the model, as t −→ ∞, as opposed to finding explicit
solutions, can be a good option here too [7]. Though the asymptotic values may
3
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not always be realistically reached.
A lot of mathematical modelling work has been done in relation to measles epi-
demics. Because measles has easily recognisable symptoms, and most cases in
developed countries are seen by doctors, the data available are often very good
[7]. Data present a bit more of a problem for modelling acute rheumatic fever.
While acute rheumatic fever is a notifiable disease in New Zealand, which provides
us with a good record, the infection data available for Group A streptococcus
infections are much more limited. This makes it more challenging to validate a
model.
2.1 Compartmental Models
In most epidemic models, the population is divided into compartments. Individuals
are sorted according to their ‘state’ in relation to the disease [7]. There are three
main types of infectious diseases, those caused by viruses, those caused by bacteria
and those caused by parasites [13].
Viral infections, such as influenza, measles and chicken pox, usually confer some
sort of immunity to reinfection once an individual recovers [7]. These types of
infections are best modelled by SIR type models. S stands the number of in-
dividuals who are susceptible to infection and could become infected if exposed
to the disease. I stands for the number of individuals who are currently infected
and may infect susceptible individuals given contact. R stands for Removed; this
compartment contains all the individuals who are immune to the disease or oth-
erwise isolated from possible infection. Removed individuals no longer affect the
transmission of the disease.
Some diseases, including Group A streptococcus, do not confer any immunity
against reinfection [7]. These types of diseases are best modelled with SIS type
models. Upon recovery, individuals move back into the Susceptible compartment
as they are once again susceptible to infection.
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2.1.1 Biological Accuracy
When developing a model, we need to be careful and pay attention to what is going
on biologically. Control strategies based on false models can sometimes do more
harm than good [7]. One of the most famous epidemics of all time is the Great
Plague of London, 1665 - 1666. The simple SIR model can fairly accurately match
the exponential rise, turnover and fall of the number of deaths due to the plague
per week [7, 16]. There are, however, some features of the data such as jagged
oscillations, that remain unexplained by this basic model [7]. If the equations of
the SIR model are replaced with stochastic processes, these can be accounted for
in the model. Even with the stochastic reformulation however, the longer term
re-emergences and extinctions of the plague cannot be explained by the simple
SIR model[7]. Biology shows, that the disease primarily infects rodents and is
spread by fleas. It is not until we take into account rodents, and the fact that
they may carry the disease when it is absent among the human population then
cause a re-emergence, that the overall pattern of the plague begins to make sense
[20]. This means that placing an infected community under quarantine will not
prevent the spread of disease to other communities. To build an accurate model
of plague transmission, the populations of fleas and rats, as well as movement in
space, needs to be taken into account [7]. Biological accuracy is very important
when developing a model for an infectious disease.
2.1.2 The SIR Model
In the SIR model the total population size is N = S + I +R. Although the num-
bers of individuals in each compartment must be integers, with sufficiently large
population sizes, we can treat S, I and R as continuous variables [7]. This allows
us to use differential equations where the rates of transfer between compartments
are derivatives of the compartment size, with respect to time [7]. The system of
differential equations for the basic SIR model is as follows
dS
dt
= −βSI, (2.1)
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S I R
βSI γI
Figure 2.1: Flow chart for the SIR epidemic model given in equations 2.1 and 2.2.
dI
dt
= βSI − γI, (2.2)
Where γ is the recovery rate. 1/γ is the time it takes for each individual to be
removed, i.e. it is the average length of time an individual is infectious for. βSI
describes the rate at which individuals are being infected. It makes sense that
the number of individuals being infected per unit of is proportional to both the
number of susceptible individuals (S) available to be infected and the number of
infectious individuals (I) that are around to infect them. β is the proportionality
constant, it represents the transmission rate per capita. β is dependent on the
infectivity of the disease in question as well as characteristics of the population we
are dealing with [7]. The fact that R does not appear in either of the equations
above reflects the fact that removed individuals do not affect disease transmission
[7]. Removed individuals are those who have either recovered from the disease
with full immunity, been isolated from the rest of the population somehow, been
immunised against infection, or have died as a result of the disease. For the simple
SIR model removal is generally seen as recovery from the disease, though isolation
due to infection could also be included as part of this [7]. So the equation for R is
simply the rate of removal of infectives.
dR
dt
= γI. (2.3)
The flow chart in figure 2.1 illustrates how individuals move between the compart-
ments.
The system of equations 2.1, 2.2 and 2.3 forms the Kermack-McKendrick ODE
model. This is a special case of the Kermack-McKendrick model, which is for-
mulated in terms of integral equations [13] and used to model the incidence of
infection [28]. The Kermack-McKendric model is given in equations 2.4 and 2.5
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below
i(t) = α(t) + S(t)
∫ ∞
0
p(τ)C(τ)i(t− τ)dτ (2.4)
S(t) = S(0)−
∫ t
0
i(τ)dτ (2.5)
t is the amount of time since the outbreak began, ie. t=0 coincides with the first
case of the disease in question in the population.
i(t) is incidence of infection, or the number of new infections per unit of time, at
time t.
α(t) represents the incidence rate of the index case. This is the number of cases
being imported into the population at time t [28]. The index case is the first case of
the infection in a particular epidemic. We can have multiple index cases however
if those cases come from outside of the population in which the epidemic is taking
place. If α(t) 6= 0, the population is not closed. The incidence of the index case is
0 in a closed population.
S(t) is the number of susceptible people in the population at time t.
τ is the time since exposure to the infection. So
∫ t
0
i(τ)dτ models the total number
of cases, that have occurred, since the beginning of the outbreak. i(t−τ) gives the
number of new cases, per unit of time, that were occurring τ units of time ago.
p(τ) is the probability that an individual infected τ units of time ago, will infect
another individual, given contact [28]. This is also known as the infectivity of the
disease [13].
C(τ) is the contact rate per host [28].
S(0) is the number of susceptible individuals in the population before the outbreak
began. So essentially, S(0) ≡ N , the population size.
We can represent the total number of infected individuals at time t by
I(t) =
∫ ∞
0
g(τ)i(t− τ)dτ (2.6)
Where g(τ) represents the probability an individual is still infectious τ units of
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time after being infected. The total number of removed individuals at time t is
R(t) =
∫ ∞
0
(1− g(τ))i(t− τ)dτ (2.7)
It is dependent on individuals no longer being infectious after τ units of time.
By assuming a constant contact rate between individuals and a constant ‘removal’
rate for infectious individuals, we can use 2.4 to derive the Kermack-McKenderick
ODE model from the three equations 2.5, 2.6 and 2.7. We are also assuming
a closed population with no new individuals entering, and no one leaving the
population. This means α(t) = 0, which is acceptable as long the timescale of
the epidemic is significantly shorter than the timescale for births, deaths and
migration. Though we still require a source of infection at t = 0.
dS
dt
= (S(0))′ − i(t)
= 0− α(t)− S(t)
∫ ∞
0
p(τ)C(τ)i(t− τ)dτ
p(τ)C(τ) represents the rate at which contacts resulting in infection are made by
an individual who was infected τ units of time ago. β represents the constant rate
a which contacts that would result in infection occur per individual. So βg(τ)
represents the rate at which an individual, who was infected τ units of time ago,
makes contacts that result in infection. hence if we assume a constant rate of
contact in the population we can use p(τ)C(τ) = βg(τ).
=⇒ dS
dt
= −S(t)
∫ ∞
0
βg(τ)i(t− τ)dτ
= −βS(t)I(t) (2.8)
=⇒ i(t) = βS(t)I(t) (2.9)
The results in 2.8 is the same as equation 2.1 [28].
If we let r(τ) be the number of infected individuals who are still infectious τ units
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of time after infection, assuming a constant rate of removal γ
dr
dτ
= −γr (2.10)
dr
r
= −γ dτ
ln(r) = c− γτ
r(τ) = r(0)e−γτ (2.11)
So if we define the rate of removal to be γ, we see that the length of the infectious
period is exponentially distributed with a mean length of 1/γ [7]. So we can
substitute g(τ) = e−γτ for the probability that an individual infected τ units of
time ago is still infectious, so that
I(t) =
∫ t
−∞
e−γ(t−τ)i(τ)dτ
= e−γt
∫ t
−∞
eγτ i(τ)dτ
⇒ dI
dt
= −γe−γt
∫ t
−∞
eγτ i(τ)dτ + e−γteγti(t)
= −γI(t) + i(t)
= −γI(t) + βS(I)
Which is the same as equation 2.2 [28].
This model only makes sense if both S(t) and I(t) are always non-negative. If
either of them reaches zero the system, and therefore the epidemic, is considered
terminated. We can clearly see from the flow chart in figure 2.1 that the population
will continue to flow from S, through I, to R until either the disease dies out, at
I = 0, or everyone is immune, R = N . S is always decreasing and I increases to a
maximum before decreasing. When this maximum happens and how big it is are
of interest[7].
In using this model we assume that each individual makes contact, capable of
resulting in infection, with βN other individuals per unit time and that infective
individuals are removed at a rate γI per unit of time. While the assumption of a
CHAPTER 2. INFECTIOUS DISEASE MODELLING 10
S I
βSI
γI
Figure 2.2: Flow chart for the SIS epidemic model given in 2.12.
contact rate proportional to population size is unrealistic, except near the start of
an epidemic, many more realistic models will exhibit similar qualitative behavior
[7].
2.1.3 The SIS Model
Some diseases, particularly those caused by bacterial infections, confer no immu-
nity on individuals who have recovered [7]. Upon recovery individuals move from
being infected back to being susceptible. Group A streptococcus is one such infec-
tion. To account for this in a model, we can modify the SIR model by removing
the equation for R and adding the term describing rate of recovery to the equation
for S. This gives us the SIS model below
dS
dt
= −βSI + γI (2.12)
dI
dt
= βSI − γI
Figure 2.2 shows the flow of infectious individuals between the Susceptible and
infectious compartments [7]. In this type of model we have N = S + I.
2.2 The basic reproduction number R0
R0 is the basic rate of disease spread at time zero with no intervention. It is
defined as the number of individuals who would be directly infected by an infec-
tious individual released into a fully susceptible population [13]. The value of R0
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is closely correlated with several important characteristics of an epidemic. The
size of peaks in the number of cases and when these peaks occur are two such
characteristics.
R0 exhibits a threshold behavior in relation to how likely it is an epidemic will
occur. If R0 > 1 a major epidemic is likely. If R0 < 1 the disease will likely die
out quickly and only a minor epidemic will occur [7].
In estimating R0 we are concerned only with the rate at which individuals enter
and exit the infectious compartment. Where they have come from and where they
recover to do not affect the reproduction number.
In the SIS and SIR models, for an infectious individual introduced into a totally
susceptible population S(0) ' N . In this case we would expect the initial rate of
infection per infected individual, at time t = 0, to be βN . That is the infectious
individual makes βN contacts, per unit of time, where the infection is passed on.
The reproduction number of a disease at any point in time is the rate at which an
infectious person is infecting others multiplied by how long they are infectious for
[7]. So if the mean infectious period is 1/γ, we would expect
R0 = βN
γ
(2.13)
R0 can also be found as the largest eigenvalue of the next generation matrix [14].
2.2.1 The Effective Reproduction Number R*(t)
We can now also defineR*, the time-dependent running reproduction number. It is
the effective rate of disease reproduction at time t, taking in to account the effects
of any intervention as well. R* represents the number of secondary infections
caused by an individual in the population who becomes infectious at time t. An
infectious individual makes C contacts per unit time, where the infection could be
passed on if that contact is made with a susceptible individual. S/N represents
the proportion of those contacts that are with susceptible individuals. Using this
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information along with equation 2.13, for the SIR and SIS models we get
R∗(t) = C
γ
× S
N
=
βN
γ
× S
N
=
βS
γ
(2.14)
If R∗ < 1 for all large t, the epidemic will die out [7]. If R∗ > 1 then the number
of infectious individuals is increasing. Because infectious individuals come from
susceptible individuals being infected, and there is no source of new susceptible
individuals in this model, an increase in I implies a decrease in S. β and γ are
both non-negative constants, so R∗ decreases as S decreases. S will continue to
decrease as long as individuals continue to become infected. This means that R∗
will continue to decrease until the disease dies out. So a disease modelled by the
SIR model will always die out [7].
For the SIS model however, individuals recover into the susceptible compartment.
In this case, when R∗ > 1 the system will tend towards an equilibrium where the
number of susceptible individuals being infected is equal to the number of infectious
individuals recovering. This is called the endemic equilibrium, as the infection
becomes endemic in the population. For the basic SIS model this equilibrium
occurs at βS = γ. So in an SIS system for,R∗ > 1,R∗ decreases asR∗ approaches
1 as t −→∞.
2.2.2 Final size
The final size of an epidemic is the total number of infections caused by a disease
before it dies out. This is another characteristic of epidemics that is predictable
given R0, or conversely can be used to estimate R0 in retrospect. Though it is
only applicable to SIR type models
Even with the basic SIR model, it is not possible to obtain an exact solution for
I(t). We can however, solve for I as a function of S by taking the ratio of equations
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Figure 2.3: Curves in the (S, I) plane produced by equation 2.16. S0 = N was
used to find c, with N = 200, β = 0.01 and γ = 0.5, 0.8, 1, 1.5. The dashed line
shows the maximum possible value of I which occurs as γ
β
−→ 0.
2.1 and 2.2 [7]
dI
dS
=
βSI − γI
−βSI
= −1 + γ
βS
(2.15)
The maximum number of individuals infectious at the same time occurs when the
derivative of I is zero, which is when βS = γ [7].
We can then integrate 2.15 to find curves in the (S, I) plane.
I = −S + γ
β
ln(S) + c (2.16)
Where c, the arbitrary constant of integration is determined by the initial values
S(0) and I(0). Figure 2.3 shows some of these curves with varying values of γ.
We define the function
V (S, I) = S + I − γ
β
ln(S),
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so that solutions are given by V (S, I) = c for all t [7].
At the start of an epidemic we have a population of size N and the number of
susceptible individuals S0 ≈ N . If a small number of infectious individuals are
introduced into a large population, we have large N , so I0 ≈ 0. By using these
two approximations and that limt−→∞ I(t) = 0, for the SIR model, we can use
V (S0, I0) = V (S∞, 0) = c where S∞ = limt−→∞ S(t) to get
N − γ
β
ln(S0) = S∞ − γ
β
ln(S∞). (2.17)
The contact rate β can be difficult to estimate as it depends on the particular
disease in question and also social and behavioural factors. We can rewrite 2.17
in terms of R0, using 2.13, to get
γ
β
(lnS0 − lnS∞) = N − S∞,
⇒ lnS0 − lnS∞ = βN − βS∞
γ
= R0 − βS∞
γ
,
⇒ lnS0 − lnS∞ = R0
[
1− S∞
N
]
. (2.18)
We may be able to estimate S0 and S∞ using blood samples, of a random sample
of the population taken before and after an epidemic. Using equation 2.18, we can
estimate what R0 was, for a particular epidemic [7]. If we know the value of R0
and S0 we can estimate what the final size of the epidemic might be.
This final size calculation is not practical for SIS type models however. If we take
the ratio of the equations in 2.12 we get
dI
dS
=
−βSI + γI
βSI − γI = −1 (2.19)
This just implies that I increases at the same rate S decreases and vice versa.
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2.2.3 Equilibrium Points
Once a disease dies out, at I = 0, no new infectious individuals can develop for
that particular outbreak. There are no infectious individuals left to infect anyone
who is susceptible. This is known as the disease free equilibrium [7].
An endemic equilibrium is when the number of infectious individuals in the pop-
ulation reaches a certain value and remains there. This usually occurs when the
rate of infection equals the rate of recovery.
We can find the equilibrium points for a particular system of equations by setting
each differential equation in the system equal to zero and solving to find the number
of individuals in each compartment[7].
2.2.3.1 SIS Equilibrium Points
For the SIS epidemic model, because N = S + I we can rewrite the system of
equations in 2.12 as
dI
dt
= −β(N − I)I + γI = 0 (2.20)
⇒ I = 0 or β(N − I) = γ
This gives us the two equilibrium points (S, I) = (N, 0) and ( γ
β
, N − γ
β
).
The stability of an equilibrium point tells us what happens to points close to it. If
an equilibrium point is unstable, all nearby points move away from it over time.
All points within a certain distance of a stable equilibrium point will move towards
it and eventually end up there. In the context of a disease model, the stability
of the equilibrium points tells what will happen if introduce the disease to the
population. If the disease free equilibrium is stable, the introduced disease will die
out, returning the model to the disease free state. If the disease free is unstable
however, as soon as we introduce the disease in to the population, we begin to
move away from the disease free state and, if it is stable, towards the endemic
equilibrium.
Either of these equilibrium points will be stable if the value of d
2I
dt2
is negative at
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that point.
d2I
dt2
= βN − 2βI − γ
The first point, (S, I) = (N, 0) is the disease free equilibrium. For the SIS model
there can only be one disease free equilibrium, because once the disease dies out
everyone recovers to the susceptible compartment. At this equilibrium point
d2I
dt2
= βN − 2β(0)− γ
= βN − γ (2.21)
This means the disease free equilibrium is stable as long as βN < γ. When
βN < γ, R0 = βN/γ < 1. So when the disease free equilibrium is stable, the
value of R0 is also telling us that an epidemic is unlikely and the disease will die
out.
The point (S, I) =
(
γ
β
,N − γ
β
)
is the endemic equilibrium. Because it is at the
point where βS = γ and S ≤ N , for this equilibrium point to exist and be valid
we require βN ≥ γ. This means the endemic equilibrium is only valid when the
disease free equilibrium is unstable. At the endemic equilibrium we get;
d2I
dt2
= βN − 2β(N − γ
β
)− γ
= βN − 2βN + 2γ − γ
= γ − βN (2.22)
So the endemic equilibrium is stable as long as βN > γ, i.e when it is valid,
R0 > 1 and the disease free equilibrium becomes unstable. This swapping of
stability through the point βN = γ is known as transcritical bifurcation [5].
2.2.3.2 SIR Equilibrium Points
For the SIR model we can use equations 2.1 and 2.2 from section 2.1.2 to find the
equilibrium points. We do not need to use the equation for R (2.3), as R does not
appear in any of the equations and N = S + I + R is constant. This means if I
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and S are not changing, R cannot be changing either. Given N , S and I, R is
easily determined [7].
dI
dt
= βSI − γI = 0 (2.23)
⇒ I = 0 or βS = γ
Setting I = 0 results in all three variables being stationary, dS
dt
= dI
dt
= dR
dt
= 0,
thus satisfying the conditions for equilibrium. Setting βS = γ results in dS
dt
=
−γI = −dR
dt
, which requires I = 0 for the system to be in equilibrium. I = 0
is the disease free equilibrium, regardless of the value of S. There are no other
equilibrium points in this system.
2.2.3.3 The Jacobian Matrix and Stability
Given a system of equations f(x1, x2 . . . xn) the Jacobian matrix is the n×n matrix
of partial derivatives [26].
J(x1, x2 . . . xn) =
[
∂fi
∂xj
]
The Jacobian matrix for this system in 2.23 is given by
J(S, I) =

∂(dS
dt
)
∂S
∂(dS
dt
)
∂I
∂(dI
dt
)
∂S
∂(dI
dt
)
∂I
 =
[
−βI −βS
βI βS − γ
]
(2.24)
If all the eigenvalues of the Jacobian matrix at the equilibrium point x have neg-
ative real parts, then the equilibrium point x is asymptotically stable [17].
The disease free equilibrium point, (S, I) = (S, 0), represents the situation where
the disease has died out after infecting a number of people who have now recovered
and moved into compartment R. S is the number of Susceptible individuals left
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who were never infected. The Jacobian matrix at this point becomes[
0 −βS
0 βS − γ
]
(2.25)
The eigenvalues of this matrix are 0 and βS − γ. This means the disease free
equilibrium is stable when βS < γ, which implies the rate of infection is less than
the rate of recovery. Because S is reduced in size as individuals become infected,
in the situation a disease is introduced where βS ≥ γ, the disease free equilibrium
is initially unstable and we move away from it, until S is reduced to the point
where βS < γ. At this point the disease free equilibrium becomes stable and the
disease starts to die out, returning the system to the disease free state.
This makes sense as βS > γ implies βS
γ
> 1, or at time t = 0, R0 > 1, which
would suggest an epidemic will occur.
2.2.4 Herd Immunity
Herd immunity occurs when some fraction of the population being immune protects
the whole population against an outbreak becoming endemic. If a fraction of the
population, p, is successfully immunised, we essentially replace N with N(1 − p)
and therefore R0 with R0(1 − p). Then for a disease to die out we then require
R0(1− p) < 1, or
1− p < 1R0 (2.26)
p > 1− 1R0 (2.27)
Smallpox is the only disease for which herd immunity has been achieved worldwide.
R0 for smallpox is approximately 5 so an 80% minimum rate of immunisation was
required to achieve this [7].
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2.3 Numerical Approximations
Initially the number of infective individuals grows exponentially and with a large
enough population size, we can approximate the equation for I, in either the SIS
or SIR model, by
dI
dt
= βNI − γI
= (βN − γ)I (2.28)
So the initial rate of growth (g), of infected individuals is
g ≡ 1
I
dI
dt
(2.29)
g = βN − γ
=
γ(βN − γ)
γ
g = γ(R0 − 1) (2.30)
This growth rate g can be estimated experimentally near the beginning of an
epidemic, based on sampling of initial cases seen by health professionals. We
could then calculate β as
β =
g + γ
N
(2.31)
This estimate should be used cautiously however. It is likely to be very inaccurate,
due to incomplete data, underreporting and misdiagnosis of cases, especially when
dealing with the outbreak of a new disease [6].
Even with the simple system of equations in the basic SIR model, we cannot
solve exactly for I(t) as an expression of t. We can however find a numerical
approximation by using small time intervals of ∆t and a computer with Euler’s
Method [15]. Though it is not the only way, Euler’s method is a simple way to
solve for the number of susceptible individuals ∆t time units into the future [7].
Using ∆S = S(t+ ∆t)− S(t) and the approximation dS/dt ' ∆S/∆t
∆S(t)
∆t
' −βS(t)I(t)
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S(t+ ∆t)− S(t)
∆t
= −βS(t)I(t)
S(t+ ∆t)− S(t) = −βS(t)I(t)∆t
S(t+ ∆t) = S(t)− βS(t)I(t)∆t (2.32)
In the same way the number of infectives at time t+ ∆t is
I(t+ ∆t) = I(t) + βS(t)I(t)∆t− γI(t)∆t (2.33)
Initial conditions for I and S are important and can make a huge difference to
the resulting model. For a disease that is persistent in the population we cannot
assume S(0) = N and I(0) = 1 as we have no idea when or even if this was ever the
case. We must instead use data available to us to choose a suitable starting point
and use those values for initial conditions [7]. Another method, the Runge-Kutta,
method us used in solving many of the later models in this thesis.
2.4 Vital dynamics
One of the problems with the previous SIR model 2.1 and 2.2 in section 2.1.2, is
it does not allow for repeat epidemics. The disease starts to die out after we reach
the point βS = γ, as the number of susceptible individuals becomes to small for
the the disease to spread as easily. It will cease to exist in the population once all
the infected persons recover.
In the case of an put break where demographic and epidemic changes take place
over similar timescales we need to include vital dynamics, such as births and deaths
in our model.this has the side effect of introducing a source of new susceptible
individuals such as newborn babies. We can include the effects of births and
deaths in the model with modified version of the basic SIR model. These vital
dynamics are independent of the disease; they are the rates of birth and death that
would exist in the population if the disease in question were absent. Assuming
that all newborns enter the population as susceptible individuals, if we let B be
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Figure 2.4: Flow chart for the SIR epidemic model with vital dynamics and a
constant population size, given by equations 2.34 and 2.35.
the birth rate and µ be the death rate we get
dS
dt
= B − βSI − µS (2.34)
dI
dt
= βSI − γI − µI (2.35)
We may also assume a constant population size for the duration of the epidemic,
as changes in birth and death rates usually take place over a much larger time
frame than an epidemic. So if we maintain a constant population size by setting
births equal to deaths we have B = µN . The flow chart in figure 2.4 shows how
individuals move in and out of each compartment when we include vital dynamics
in the SIR model and keep the population constant.
By including these vital dynamics we can produce oscillations in our model that
correspond to recurrent epidemic data seen in real populations. However, unlike
the oscillations seen in the data, our oscillations that occur solely with the in-
troduction of vital dynamics damp out over time to eventually reach an endemic
equilibrium. In fact it can be proven that this equilibrium is globally asymptoti-
cally stable. So no matter what the starting conditions or the values of the other
parameters are, the solutions will always converge on the equilibrium. Because of
this, the basic SIR model with vital dynamics alone is not enough to explain the
oscillations seen in the data for most recurring epidemics that show a oscillating
pattern [7]. We may need to introduce more complex elements to the model to
more accurately represent the behaviour of an infection in the population.
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2.4.1 SIR Equilibrium points with vital dynamics
To find the equilibrium points for the SIR model with vital dynamics, we set
equations 2.34 and 2.35 equal to zero. Using B = µN for a constant population
size we solve for S and I.
dI
dt
= βSI − γI − µI = 0
⇒ βS = γ + µ or I = 0
If we substitute each of these values into equation 2.34 we get the following
If I = 0
µN − µS = 0
µS = µN
S = N
If βS = γ + µ
µN − (γ + µ)I − µ(γ + µ)
β
= 0
µN − µ(γ + µ)
β
= (γ + µ)I
I =
µN
γ + µ
− µ
β
So the two equilibrium points are (N, 0) and
(
γ+µ
β
, µN
γ+µ
− µ
β
)
.
The Jacobian matrix for this system 2.34 and 2.35 is given by
J(S, I) =

∂(dS
dt
)
∂S
∂(dS
dt
)
∂I
∂(dI
dt
)
∂S
∂(dI
dt
)
∂I
 =
−βI − µ −βS
βI βS − γ − µ
 (2.36)
The disease free equilibrium, at (N, 0) represents a population where the disease in
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question has died out and all those who recovered from the disease have also died,
at the usual death rate. As soon as the disease stops spreading we are headed for
this equilibrium and the equation for Susceptibles S heads towards an equilibrium
at I = 0. However the number of individuals in the Removed compartment R
continues to shrink at the rate µR, therefore the system does not technically reach
equilibrium until R = 0 as well. The Jacobian matrix at this equilibrium becomes
[
−µ −βN
0 βN − γ − µ
]
(2.37)
This matrix has eigenvalues −µ and βN − γ − µ, so the equation is stable when
βN < γ + µ.
Because βN ≥ βS = γ + µ at the endemic equilibrium,
(
γ+µ
β
, µN
γ+µ
− µ
β
)
, it is only
valid as long as βN ≥ γ + µ. This also ensures that the number of individuals
in the infectious compartment remains non-negative. The Jacobian matrix at this
equilibrium point becomes
[
−βµN
γ+µ
−γ − µ
βµN
γ+µ
− µ 0
]
(2.38)
The eigenvalues for this matrix are not very simple, however there is another way
to determine the stability of an equilibrium point.
Let us define a matrix M
M =
[
A B
C D
]
(2.39)
M has determinant |M | = AD − BC and trace tr(M) = A + D. To find the
eigenvalues we find the roots of the characteristic equation given by |M −λI| = 0,
where I is the identity in this case and λ is an eigenvalue.
|M − λI| = 0
⇒ (A− λ)(D − λ)−BC = 0
⇒ λ2 − λ(A+D) + AD −BC = 0
⇒ λ2 − tr(M)λ+ |M | = 0 (2.40)
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So if tr(M) < 0 and |M | > 0 then the roots of the characteristic equation 2.40,
and hence the eigenvalues of M both have negative real parts [13].
The Jacobian matrix for the endemic equilibrium in this system 2.38 has determi-
nant βµN − µ(γ + µ) = µ(βN − γ − µ) which is positive if βN > γ + µ.
The trace is −βµN
γ+µ
, which is always negative as all of the parameters and compart-
ment sizes are non-negative.
So the endemic equilibrium is stable as long as βN > γ + µ. This is similar to
analysis seen in Brauer [7].
2.5 Stochastic Epidemic Models
In the previous sections, by using differential equations we are treating I and S as
continuous variables. As discussed previously this is quite reasonable for a large
population size N . However this assumption still has some observable effect on
the predictions of the model. By adding a small amount of noise to the model, or
replacing it with a stochastic version, we can account for the fact that I and S
are actually discrete variables, or that some things don’t happen deterministically.
Doing this also prevents the oscillations in the previous model 2.34 and 2.35 from
damping out [7].
2.5.1 Discrete Time Markov Chain Models
Using Markov chains, we can derive realistic stochastic models that are based on
our deterministic models. Let pji= the probability of transition from state I(t) = i
to state I(t+ ∆t) = j during the time interval ∆t. This is the probability that the
number of infectious individuals changes from i to j over the time step ∆t. For
a simple discrete time model we choose ∆t to be small enough that at most one
transition can take place during the time step. This means j = i− 1, j = i+ 1 or
j = i [7].
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2.5.1.1 The SIS DTMC model
For the SIS epidemic model, using a Discrete Time Markov Chain or DTMC
model, the transition probabilities look like this
pji(∆t) =

βi(N − i)∆t j = i+ 1
(µ+ γ)i∆t j = i− 1
1− [βi(N − i) + (µ+ γ)i]∆t j = i
0 otherwise
(2.41)
This shows the probabilities for each possible change in the number of infectious
individuals over one time step ∆t. The probabilities are based on the differential
equations for the SIS model with vital dynamics, µ = birth-rate = death-rate.
The probability that the number of infectious individuals decreases by one is the
sum of the probability that an infectious individual dies and the probability that
an infectious individual recovers. These probabilities are determined by the death-
rate µ and the recovery rate γ in the differential equations for the SIS model with
vital dynamics.
Figure 2.5 shows a plot of some sample paths produced by the SIS DTMC transi-
tion probabilities, along with the curve produced by the deterministic SIS model.
The sample paths were produced in Matlab, a random number between 0 and 1,
was chosen from a uniform distribution and used with the transition probabilities
in 2.41, to decide the change in the number of infectious individuals at each time
step. The code for how this was done is given in Appendix A.1.
Two of the sample paths presented in Figure 2.5 follow the deterministic plot,
fairly well, towards the endemic equilibrium. The green path however, shows the
number of infected individuals dying out near the start of the plot, leaving us
with the disease free state. This is an example of one characteristic of stochastic
epidemic models, there is always the possibility that the disease will start die out,
from any point in the epidemic, reaching in the disease free equilibrium regardless
of the parameter values and what is predicted by the deterministic model.
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Figure 2.5: Three sample paths of the DTMC SIS model in 2.41. The dashed line
shows the deterministic model. The different colours show the different sample
paths. For all three sample paths the time step ∆t = 0.01, N = 100, β = 1, µ =
0.1, γ = 0.25.
2.5.1.2 The SIR DTMC model
For the SIR Epidemic Model with vital dynamics, the DTMC model is based
on equations 2.34 and 2.35 from section 2.4. The transition probabilities are as
follows
p(s+k,i+j),(s,i)(∆t) =

βis
N
∆t (k, j) = (−1, 1)
γi∆t (k, j) = (0,−1)
µi∆t (k, j) = (1,−1)
µ(N − s− i)∆t (k, j) = (1, 0)
1− [βis
N
∆t+ γi+ µ(N − s)]∆t (k, j) = (0, 0)
0 otherwise
(2.42)
p(s+k,i+j),(s,i)(∆t) is the probability that the number of individuals in compartment
S changes from s to s + k and the number of individuals in I changes from i to
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i + j over the time step ∆t We have a constant population size N and birth-rate
= death-rate=µ. Because we are assuming all newborns are susceptible, a birth
results in an increase in the number of susceptible individuals. Because of the
constant population size, a birth also results in a death. If this is an infected
individual, we have (k, j) = (1,−1). This has a probability µi∆t of occurring over
one time step. If a birth is balanced by a death among the susceptible population,
we would see no change in numbers, i.e. (k, j) = (0, 0). If the birth is balanced by
the death of a recovered individual, we only see the increase in S, (k, j) = (1, 0)
[7].
Combining these transition probabilities together, we can get an equation for the
probability that S = s and I = i at time t+ ∆t.
p(s,i)(t+ ∆t) = p(s+1,i−1),(s,i)(t)
β
N
(i− 1)(s+ 1)∆t+ p(s,i+1),(s,i)(t)γ(i+ 1)∆t
+ p(s−1,i+1),(s,i)(t)µ(i+ 1)∆t+ p(s−1,i),(s,i)(t)µ(N − s+ 1− i)∆t
+ p(s,i),(s,i)
(
1−
[
β
N
is+ γi+ µ(N − s)
]
∆t
)
(2.43)
Figure 2.6 shows some sample paths for the SIR DTMC model, along with the
curve from the deterministic model. These sample paths were produced in the
same way as those for the SIS DTMC model. Because of the added compartment
R there are more possible transitions at each time step. In the SIS model a recov-
ery from infection had the same effect as the death of an infected individual, In the
SIR stochastic model however, a recovery increases the size of the removed com-
partment and does not affect the size of S. The red sample path dies out near the
beginning, resulting in a disease free state early on, this is another example of how
a stochastic model may die out despite the predictions made by the deterministic
model.
2.5.2 Continuous Time Markov Chain Models
The DTMC models described above are defined on discrete time steps, where one
individual changes state at each step. The problem with this type of model is that
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Figure 2.6: Three sample paths of the DTMC SIR model in 2.42. The dashed
line shows the deterministic model. The different colours show the different sample
paths. For all three sample paths the time step ∆t = 0.01, N = 100, β = 1, µ =
0, γ = 0.25,.
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we need to be very careful choosing the size of the time step. Too small a time
step and the program takes too long to run, too large a time step and we start to
underestimate the change in the population.
One way of overcoming this issue is to use continuous time. A Continuous Time
Markov Chain (CTMC) model looks fairly similar to the DTMC model. The
transition probabilities are still defined for a small time interval ∆t, but they
are referred to as infinitesimal transition probabilities because they are valid for
infinitesimally small ∆t. By excluding terms o(∆t) in the definitions of the in-
finitesimal transition probabilities, where lim∆t−→0(o(∆t)/∆t) = 0, we are able to
vary the sizes of the time steps in a exponential distribution and simulate contin-
uous time [7]. For the SIS CTMC model the infinitesimal transition probabilities
are defined as follows:
pji(∆t) =

β
N
i(N − i)∆t+ o(∆t) j = i+ 1
(µ+ γ)i∆t+ o(∆t) j = i− 1
1− [ β
N
i(N − i) + (µ+ γ)i]∆t+ o(∆t) j = i
0 + o(∆t) otherwise
(2.44)
To produce a plot for this model we let ∆t = −log(u1)/a, where u1 is a uniform
random number and a is the probability of change in a time step, a = 1− pi,i(∆t).
We then use another random number u2 to decide what type of change occurs in
that time step.
Figure 2.7 shows a few of the sample paths produced using the SIS CTMC transi-
tion probabilities. Again one of the sample paths shows the disease dying out near
the start instead of heading to the endemic equilibrium. While it is possible for a
stochastic model to die at from any point in the epidemic, it is usually unlikely.
In each model we have shown, the disappearing sample path has died out near
the begging of the epidemic when numbers of infectious individuals are low. this
shows the vulnerability of the disease to small changes in the initial stages of an
epidemic.
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Figure 2.7: Three sample paths of the CTMC SIS model in 2.44. The dashed
line shows the deterministic model. The different colours show the different sample
paths. For all three sample paths the time stepN = 100, β = 1, µ = 0.1, γ = 0.25,
.
Chapter 3
Acute Rheumatic fever
Acute rheumatic fever is an autoimmune response following an infection by Group
A streptococcus bacteria [18]. Group A streptococcus is often presented as strep
throat and less often as scarlet fever [1], though there is a recent hypothesis that
a skin infection by Group A streptococcus may be responsible for acute rheumatic
fever in some communities [11].
If a Group A streptococcus infection is not properly treated, acute rheumatic
fever can develop after 2 to 3 weeks [31]. After apparent recovery, the individual
experiences an inappropriate immune response. This response is thought to be due
to molecular similarity between products of Group A streptococcus degradation
and certain human tissues. The heart, joints and central nervous system are the
three places this similarity occurs. Acute rheumatic fever is very rare among young
children, under the age of 3 [24]. The highest risk coincides with the maturation
of the immune system at around ten years of age [31]. First time infections of
acute rheumatic fever typically occur in children aged between the ages of 5 and
17 [11, 24]. 92% of cases occur in children under the age of 18 [24].
3.1 Symptoms and Diagnosis
Accurate diagnosis of acute rheumatic fever can be an issue and there is currently
no definitive laboratory diagnostic test for it [18]. Because of this, diagnosis is
31
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done clinically with laboratory tests used to support the diagnosis [24].
A patient is usually asymptomatic for about three weeks following the Group A
streptococcus infection [1].
Symptoms are described in terms of the Jones criteria, where a combination of
major and minor symptoms are used to determine the likelihood that a patient
has acute rheumatic fever.
Polyarthritis, affecting the knees elbows, wrists and ankles, accompanied by fever,
is the initial warning sign. The hips and spine may also, occasionally, be affected.
The arthritis is a major symptom but is only seen in 75% of cases.
Carditis, another major symptom, usually occurs within three weeks. This is re-
vealed by cardiac sonography in 70% of cases. Carditis, together with polyarthritis
and fever, strongly supports the diagnosis of acute rheumatic fever. Skin signs,
such as subcutaneous nodules are rare but may also be observed [24].
Under or over diagnosis in different regions could affect data and recorded incidence
in some areas [18]. In the absence of any other explanation however, a diagnosis of
rheumatic fever may be given even if symptoms are incomplete. Though if there is
abdominal pain initially, the diagnosis of rheumatic fever may be invalidated [24].
3.2 Susceptibility and Prevention
Not all individuals infected with Group A streptococcus will develop acute
rheumatic fever if untreated. Only certain individuals are susceptible to the dis-
ease. 0.3% to 3% of a general population will develop acute rheumatic fever fol-
lowing a Group A streptococcus infection [1, 11]. The incidence is much higher
among individuals who have had previous attacks of acute rheumatic fever with
about 30% to 80% having a recurrence of acute rheumatic fever following a Group
A streptococcus infection [1]. Interestingly, there is also a higher incidence of acute
rheumatic fever among relatives of patients who have, or have had, the disease,
when compared with unrelated individuals. It has been noted in past studies that
individuals with a family history of acute rheumatic fever are nearly five times
more likely to acquire the disease [8]. This suggests a genetic susceptibility to
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acute rheumatic fever [1, 11]. Genetic predisposition is also supported by twin
studies where monozygotic twins showed greater similarity in their susceptibility
when compared with dizygotic twins, though the lack of greater similarity in sus-
ceptibility suggests a complex pattern of inheritance [8]. It also suggests there is a
role played by environmental factors in determining susceptibility. There is a long
held belief that individuals who are susceptible to acute rheumatic fever also show
a hyper reactive immune response to Group A streptococcus antigens [1].
There is usually no increased resistance or susceptibility among particular races or
ethnic groups. An outbreak in America in the 1980’s however, did occur among
middle-class white children with no apparent risk factors aside from possible over-
crowding. The degree to which host risk factors are inherited or acquired is unclear
[31].
Surveillance involving the collection of epidemiological data is required, to identify
‘at risk’ groups and help direct control efforts [11].
Recurrence of acute rheumatic fever is relatively common, especially in the 3-5
years following a previous episode [24]. Prevention of recurrent attacks is impor-
tant, as they can lead to permanent damage to the heart valves. The most cost
effective way of preventing rheumatic heart disease is to prevent recurrences of
acute rheumatic fever [11]. Regular injections of penicillin (usually monthly), for
at least five years following an acute rheumatic fever attack, are used to prevent
recurrences. The length of this secondary prophylaxis is dependent on the severity
of an individual’s previous acute rheumatic fever attacks [11, 31]. Susceptibility
to recurrence of acute rheumatic fever is reduced with age [31].
Giving antibiotics to patients with sore throats and other symptoms suggestive of
Group A streptococcus remains the only way to prevent primary attacks of acute
rheumatic fever. That is besides improving access to medical care and eliminating
poverty and overcrowding [11]. There has never been a documented case of Group
A streptococcus being resistant to penicillin anywhere in the world [4]. Acute
rheumatic fever still lacks a vaccine, but if we can learn more about susceptible
hosts and how to identify them, prevention of the disease could be greatly simplified
[31].
With appropriate health care programs and good medical care, the burden of acute
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rheumatic fever can be reduced [11].
3.3 Treatment and Recovery
There is no treatment for acute rheumatic fever. The treatment received by a
patient with acute rheumatic fever is purely symptomatic, aside from treatment
for heart failure if necessary [19]. The main aim of treatment is to eliminate any
remaining Group A streptococcus from the original infection and suppress the
inflammation caused by the acute rheumatic fever [10]. Following such treatment,
acute rheumatic fever attacks usually cease within 2 months of the initial Group
A streptococcus infection. Any relapses after this period are likely to be due to a
new infection [32].
3.4 Group A Streptococcus
Acute pharyngitis is one of the most common illnesses seen by paediatricians and
other primary care physicians [3]. Streptococcus pyogenes strains commonly re-
ferred to as Group A Streptococci [1], are the most frequent bacterial cause [12].
It is primarily a childhood disease occurring mostly in children aged between 5
and 15 [12].
Group A Streptococcus is spread through inhalation or contact with secretions
from infectious individuals [29]. In temperate climates it usually appears in winter
and early spring. During this time of year up to 20% of asymptomatic children
may be streptococcus carriers. These carriers, however, are unlikely to spread the
organism to their close contacts and are at low risk of complications such as acute
rheumatic fever.
A ‘Ping-pong’ effect can occur within family groups, where the infection bounces
between family or household members as they infect each other and recover. Ap-
proximately 25% of individuals within the household of an index patient may also
harbour Group A streptococcus in their upper respiratory tract. There is no cred-
ible evidence that family pets may contribute to familial spread.
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Most asymptomatic patients with Group A streptococcus remaining in the upper
respiratory tract after a course of antibiotics are streptococcal carriers. While this
may mean persistence of the infection in that individual, the circumstances that
lead to such asymptomatic carriage usually mean the infection has relatively low
virulence. This means asymptomatic carriage has negligible influence in infection
models [12]. A small percentage of patients have recurrences of acute pharyngitis
associated with Group A streptococcus, shortly after completion of a course of
antibiotics [3].
3.4.1 Symptoms and Diagnosis
Symptoms of Group A streptococcus infection usually develop after an incubation
period of 24 to 72 hours [29]. There is a large overlap between streptococcal and
viral pharyngitis in terms of symptoms. Less than half of patients with acute
pharyngitis are actually infected with Group A streptococcus. Symptoms include
sudden onset of a sore throat, pain on swallowing and fever. Headache, nausea,
vomiting and abdominal pain may also be present, especially in children. None of
these symptoms however are specific to Group A streptococcus. It can also be dif-
ficult to distinguish between a Group A streptococcus carrier currently suffering a
non-Streptococcal infection, from a patient with Acute Streptococcal pharyngitis,
though the absence of fever or the presence of symptoms such as conjunctivitis,
cough, diarrhoea, suggests viral rather than bacterial infection. Because of the
overlap in symptoms with viral infections, unless Group A streptococcus can be
confidently excluded, a laboratory test should be performed to determine if it is
present or not [4]. The most reliable method for detecting the presence of Group
A streptococcus in the throat is by culturing a throat swab [12]. Streptococ-
cal pharyngitis is also a self-limiting disease with symptoms disappearing spon-
taneously within 3-4 days. Rapid identification and treatment of streptococcal
pharyngitis can reduce the risk of spread as well as the acute morbidity associated
with the disease [4].
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3.4.2 Treatment and Recovery
Effective treatment of a Group A streptococcus infection reduces the risk of acute
rheumatic fever by about 90% [24]. Penicillin, as a treatment for Group A strep-
tococcus, is preventative against acute rheumatic fever [24]. Treatment with peni-
cillin will also reduce the duration of symptoms by 1 or 2 days [29]. Erythromycin
is a suitable substitute in the case of patients who are allergic to penicillin [4].
Antimicrobial therapy has no benefit however, in treating pharyngitis that is not
caused by Group A streptococcus. Its use in such situations unnecessarily exposes
patients to expense and hazards as well as possibly contributing to the emergence
of antibiotic-resistant bacteria. It has been shown that therapy can be postponed
for up to 9 days after symptoms first appear, and still safely prevent the onset of
acute rheumatic fever [4]. An untreated Group A streptococcus infection will last
for 7 to 10 days [29]. In about 10% of cases, Group A streptococcus will remain
present in the throat even after adequate treatment [24]. For patients whose
symptomatic episodes do not decrease in frequency over time, without alternative
explanation, surgical removal of the tonsils may be considered. Throat cultures
should be performed regularly for patients with a history of acute rheumatic fever
[4].
Vaccines for Group A streptococcus are currently being investigated. One impor-
tant issue with the vaccine is that it does not itself, induce the acute rheumatic
fever it is intended to prevent [12].
3.4.3 Rheumatogenic Strains
Infection of the throat, by Group A streptococcus, is usually required for acute
rheumatic fever to be a risk [24]. Studies have shown Group A streptococcus
strains that colonise the skin are rarely associated with cases of acute rheumatic
fever [31]. Not all infections due to Group A streptococcus can result in acute
rheumatic fever. Those that do are considered extremely virulent and the attack
rate of the resultant acute rheumatic fever is dependent on the host’s immune
response [31]. The onset of acute rheumatic fever in an individual may be the
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result of an increase of virulence in a specific strain of Group A streptococcus [24].
Identifying the particular strains that lead to acute rheumatic fever can be difficult
however, as often patients do not remember having a sore throat. By the time
acute rheumatic fever is diagnosed, the infecting strain is often gone [31]. While
the separation of skin and throat strains of Group A streptococcus is fairly simple,
the differences between throat strains associated with acute rheumatic fever and
those that are not is not clear other than their differing levels of virulence [31].
There appears to be some seasonal variation, such that throat colonising Group
A streptococcus is not often associated with acute rheumatic fever during the
summer. It is during the winter that acute rheumatic fever follows Group A
streptococcus [31].
Overall the development of acute rheumatic fever and its severity is thought to
depend on the genetic susceptibility of an individual, the virulence of the Group
A streptococcus strain, environmental factors and an abnormal immune response
[8, 11].
3.5 New Zealand Infection Rates
In a study conducted by Jaine et.al. annual rates of first time acute rheumatic
fever cases in New Zealand between 1996 and 2005 were found to be 3.4 per 100
000. This is an average of 125 first time acute rheumatic fever hospital admissions
per year [18].
There also appears to be a strong ethnic association with acute rheumatic fever
in New Zealand, making ethnicity an important risk factor. While New Zealand
European and other ethnicities have seen a significant drop in acute rheumatic
fever rates, there have been increases among Maori and Pacific peoples such that
overall rates in New Zealand have not dropped since the 1980’s. The highest
estimated incidence of acute rheumatic fever among school children is in Sub-
Saharan Africa, but the highest published incidence in recent times is among the
indigenous populations of Australia and New Zealand [11]. Rates among Maori
are approximately 22 times that of New Zealand Europeans, and Pacific peoples
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Figure 3.1: Rheumatic fever rates for 2010 by age group and ethnicity. Rates are
per 100 000 population. This was sourced from the New Zealand public health
observatory website, Notifiable disease page. The numbers of acute rheumatic fever
amoung the other ethnicities do not show up here because they are too small, they
represent only 6 cases in total or 0.000076 per 100 000 individuals.
have a rate 75 times greater [18]. Figure 3.1 shows the rates for different ethnicities
and age groups in 2010.
As the graph in Figure 3.1 shows, acute rheumatic fever is a huge issue among
Maori and Pacific peoples, while barely affecting any other ethnicities. In 2010
there were 104 cases among Maori, 58 among Pacific peoples and 6 cases among
all the other ethnicities together.
In New Zealand recurrences are again, more likely to occur among the Maori and
Pacific peoples, when compared with the rest of the population, accounting for
well over 90% of recurrent cases. Overall recurrence rates in New Zealand are low,
with an average of only six cases per year for the years 1996 to 2005 [18].
New Zealand continues to maintain a high rate of acute rheumatic fever for a
developed country. Table 3.1 gives rates of acute rheumatic fever from around the
world [9]. We can easily see how much more prevalent acute rheumatic fever is
among the maori, aboriginal and pacific island populations comapared with other
ethnicities and regional populations.
Figure 3.2 shows the number of acute rheumatic fever cases seen by health profes-
sionals in New Zealand each month since 1997.
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Region Median incidence* Annual No. cases
Sub-Saharan Africa 13.4 24000
South central Asia 54.0 184000
Asia other 21.2 26500
Latin America 19.6 21000
Middle east and north Africa 13.4 11000
Eastern Europe 10.2 4000
Pacific & indigenous Australia/NZ 374.0 8000
Established market economies** 10.0 11000
China 21.2 47000
Total aged 5-14 years .. 336500
Total all ages† .. 471000
* cases per 100,000.
** Non-indigenous Australia and New Zealand, Western Europe,
Northern Europe, Southern Europe, Northern America and Japan
† Assumes 40% of all acute rheumatic fever cases occur over 14 years of age.
Table 3.1: Estimated annual number of acute rheumatic fever cases in children
aged 5-14 years, and extrapolation to all ages [9].
Figure 3.2: Rheumatic fever cases by month since 1997. This was sourced from
the New Zealand public health observatory website, Notifiable disease page.
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Figure 3.3: Rheumatic fever cases by month since 1997 summed together. Data
were sourced from the New Zealand public health observatory website, Notifiable
disease page.
Geographically incidence is highest in the upper North Island with low incidence
in the South Island. This geographic variation is strongly correlated with ethnic
distribution in New Zealand.
Acute rheumatic fever is a notifiable disease in New Zealand [18]. This means
medical practitioners are required to notify local medical health officers of any
acute rheumatic fever diagnoses they make. Failure to do so is an offence against
the health act [22]. The numbers of reported cases, between 1996 and 2005, peak
around early winter for the months June - August. The lowest incidence was
recorded in October, November and December [18]. Figure 3.3 shows the monthly
pattern a bit more clearly.
These patterns in age, ethnicity and season give us some things to focus on in
developing a model for disease incidence.
Chapter 4
A Basic Model for Rheumatic
Fever
4.1 Building the Basic Model
As we saw in Chapter 3, acute rheumatic fever is an autoimmune response to in-
fection by Group A streptococcus. This means individuals are moving from being
infected to developing acute rheumatic fever. If we label the infected compartment
I and the compartment containing those with acute rheumatic fever as A, indi-
viduals flow from I to A, as shown in Figure 4.1, at the rate they develop acute
rheumatic fever.
The infected individuals must come from somewhere, so we need a compartment
that contains those individuals susceptible to infection. This is the Susceptible
compartment which we will label S. As Figure 4.1 shows, susceptible individuals
move from S to I as they become infected and from there move on to A.
Because Group A streptococcus is an illness from which no immunity is retained
upon recovery, we need an SIS type model. All individuals move back to the
susceptible compartment as they recover. Individuals may recover from either the
I or A compartment as not everyone develops acute rheumatic fever after having
a Group A streptococcus infection. Figure 4.1 shows the flow of individuals once
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S I A
βSI
γI
ωI
κA
Figure 4.1: Flow chart for the SIAS epidemic model, given by 4.1, showing the
rate of movement between compartments as individuals move from Susceptible,
though Infectious to developing Acute rheumatic fever, and the different paths
they can take back to the Susceptible compartment.
we add in recovery.
We will refer to this as the SIAS model. The differential equations for this model
are shown in 4.1 below.
dS
dt
= −βSI + γI + κA
dI
dt
= βSI − γI − ωI (4.1)
dA
dt
= ωI − κA
The rate of new infections is proportional to both the number of susceptible indi-
viduals and the number of infectious individuals. β is the proportionality constant
and represents the rate of contact resulting in infection. γ is the rate of recovery
of infected individuals back into the susceptible population. ω is the rate at which
infected individuals develop acute rheumatic fever and κ is the rate at which they
recover. Figure 4.1 shows the flow of individuals and the rates at which they move
between compartments in this basic model.
4.1.1 Assumptions
For this model we are assuming individuals with acute rheumatic fever are no
longer infectious but cannot be infected either. Though individuals with acute
rheumatic fever may still retain some bacteria, this is minimal and often gone
by the time they are diagnosed [31], and due do the immune response resulting
in acute rheumatic fever they are unlikely to contract a new infection while in
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compartment A. We are also assuming we have a homogeneous population where
individuals mix evenly and each individual has the same chance of being infected
and developing acute rheumatic fever.
N = S + I + A is the total population size. In this model we are assuming the
population size is constant, therefore dS
dt
+ dI
dt
+ dA
dt
= 0. This means we can use
A = N − S − I to substitute for A. The acute rheumatic fever compartment
works a bit like an R class in an SIR type model, it contains individuals who were
infected and are temporarily immune to reinfection. While A does have an effect
on the dynamics of S and I, we can easily find A from S, I and N at any point.
Substituting A = N − S − I into 4.1 gives us the reduced system
dS
dt
= −βSI + γI + κ(N − S − I) (4.2)
dI
dt
= βSI − γI − ωI
4.2 Equilibrium Points for the SIAS Model
We find the equilibrium points in the same way we found them for the SIS and
SIR models in section 2.2.3. First set the righthand side of each equation equal
to zero, Then solve for S and I. The second equation from 4.2 gives us
βSI = γI + ωI
⇒ I = 0 or βS = γ + ω
If I = 0 the first equation of 4.2 gives us
κN = κS
N = S
κ is the constant rate of recovery from acute rheumatic fever and non-zero. So the
first equilibrium point is at (N, 0). This is the disease free equilibrium.
If I 6= 0 then we have βS = γ + ω. By substituting this into the first equation of
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4.2 we get
−I(γ + ω) + γI + κN − κ(γ + ω)
β
− κI = 0
−I(ω + κ) + κ
(
N − γ + ω
β
)
= 0
I(ω + κ) = κ
(
N − γ + ω
β
)
I =
κ(βN − γ − ω)
β(ω + κ)
(4.3)
giving us the endemic equilibrium point at
(S, I) =
(
γ + ω
β
,
κ(βN − γ − ω)
β(ω + κ)
)
.
4.2.1 Stability of the Equilibrium Points
To determine the stability of each equilibrium point we find the Jacobian matrix
for 4.2 [
−βI − κ −βS + γ − κ
βI βS − γ − ω
]
(4.4)
At the disease free equilibrium (N, 0) this becomes[
−κ −βN + γ − κ
0 βN − γ − ω
]
(4.5)
which has two eigenvalues, −κ and βN − γ − ω. Because −κ < 0 always, the
disease free equilibrium is stable if βN < γ + ω and unstable if βN > γ + ω. This
makes sense because if the initial rate of infection, βN , is less than the rate at
which individuals leave the infectious compartment, γ + ω, then the infectious I
will shrink faster than it grows until the disease dies out in the population.
At the endemic equilibrium (S, I) =
(
γ + ω
β
,
κ(βN − γ − ω)
β(ω + κ)
)
we get the Jaco-
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bian matrix −κ(βN − γ + κ)ω + κ −ω − κκ(βN − γ − ω)
ω + κ
0
 (4.6)
Fixed points are stable if the determinant of the Jacobian matrix is positive and
the trace is negative. The determinant of the Jacobian matrix 4.6 is
(ω + κ)× κ(βN − γ − ω)
ω + κ
= κ(βN − γ − ω) (4.7)
Which is positive if βN > γ + ω.
The trace of this matrix is −κ(βN − γ + κ)
ω + κ
(4.8)
Which is negative if βN > γ − κ. For κ > 0,
γ − κ < γ < γ + ω.
So this equilibrium point is stable as long as βN > γ + ω.
This is similar to what we saw in Section 2.2.3.1 with the endemic equilibrium
for the SIS model. The condition of stability of this equilibrium point is also
a condition for the valid existence of this equilibrium point. At the endemic
equilibrium βS = γ + ω, so βN must be greater than βS, as N = S + I + A
and to be biologically realistic we cannot have a negative number of individuals
in any compartment. This means βN > βS = γ + ω for this equilibrium point to
realistically exist. That is, when the equilibrium is achievable it is also stable. The
change of stability about the point βN = γ+ω, is again an example of transcritical
bifurcation.
To find the nature of A and its value at each equilibrium point we can use N =
S + I + A and substitute the appropriate values into 4.1. Note that A is also
stationary at the equilibrium points since A = N−S−I and S and I are stationary.
So at (N, 0), A = 0.
This makes sense as when S = N everyone is in the susceptible compartment.
There are no individuals with acute rheumatic fever or in the infected compartment
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Figure 4.2: A plot of a numerical solution to the SIAS model 4.1. with N =
100, β = 0.01, γ = 0.4, ω = 0.2, κ = 0.8 and 2 initial infectious individuals.
Under these conditions the numbers of Group A streptococcus (Strep= I) and
acute rheumatic fever (ARF= A) head to an equilibrium at 32 and 8 respectively
.
to be at risk of developing acute rheumatic fever.
At the endemic equilibrium
A =
ω(βN − γ − ω)
β(ω + κ)
=
ωI
κ
.
A is directly proportional to I. This is also clear from the third equation in 4.1.
dA
dt
= 0 =⇒ ωI = κA
CHAPTER 4. A BASIC MODEL FOR RHEUMATIC FEVER 47
4.3 Triangle of Validity
Because N = S + I + A is constant we can ‘decouple’ A from the system of
equations as was done in 4.2. We cannot drop it entirely however. Aside from A
being the compartment we are interested in in the first place, it also has a large
influence on the values of I and S and their valid existence.
The endemic equilibrium point is at βS = γ+ω. S ≤ N always, so for the endemic
equilibrium to have valid values of S and I, we require βN > γ + ω. The disease
free equilibrium is at S = N and is stable as long as βS = βN < γ + ω. This
puts the endemic equilibrium outside the ‘triangle of validity’, or valid range of
possible values for S and I, as βS = γ + ω > βN is an unrealistic scenario.
If we plot I against S and join the points (N − A, 0) and (0, N − A) to represent
the boundary above which points are no longer valid, we get a triangle. Figure
4.3 shows this along with a numerical solution of 4.1 with infectious individuals
plotted against the number of susceptibles.
So for the endemic equilibrium to be valid the disease free equilibrium must lose
its stability. It also means that when the endemic equilibrium has valid values, it
has a negative trace and positive determinant. So when it is valid, the endemic
equilibrium is always asymptotically stable. Under the conditions at which the
endemic equilibrium is unstable it is outside of the ’triangle of validity’.
This change of stability about the point βN = γ + ω = βS is an example of
transcritical bifurcation [33]. In this case either the disease free equilibrium is
always valid, but is unstable when the endemic equilibrium exists. The endemic
equilibrium only exists when the disease free equilibrium is unstable, the endemic
equilibrium is always stable when it exists.
We saw this same, transcritial bifurcation, behaviour in our analysis of the SIS
model in section 2.2.3.1.
Theoretically the same triangle of validity, seen in our SIAS model can apply to
the SIR model. The problem is that there is no feedback into S from either I or
R so R gets bigger and the triangle decreases in size until I = 0.
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Figure 4.3: A plot of I against S for SIAS model. N = 100, β = 0.1, γ =
0.4, ω = 0.2, κ = 0.8 with 2 initial infectious individuals. The line curves down
before we reach S = 0 as this can only happen if β −→∞ or if γ + ω = 0, i.e. we
have no recovery. The solid blue line shows the direct line between (S, I) = (0, N)
and (S, I) = (N, 0)
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4.3.1 R0 for the Basic SIAS Model
In section 2.2, equation 2.13, we defined the basic reproduction number R0 for the
SIR model as
R0 = βN
γ
This is the rate of infection of susceptible individuals in a fully susceptible pop-
ulation, (ie. when S = N) divided by the rate at which individuals leave the
infectious compartment [7]. For our acute rheumatic fever model this would mean
R0 = βN
γ + ω
It is instructive to relate R0 to the stability of the equilibrium points. When
the endemic equilibrium is valid βN > γ + ω and R0 > 1, meaning more than
one susceptible individual is infected by each infected individuals, which would
imply an epidemic is likely to occur. It makes sense that this threshold is reached
simultaneously with the appearance of a stable endemic equilibrium.
4.4 A Basic Stochastic Model
Using our basic acute rheumatic fever model, we can derive a set of transition
properties similar to what was done for the SIR model in equation 2.42 and the
SIS model in section 2.5.2. Using S = N − I − A we can show the probability
of a single change of state. This is the probability that one individual changes
compartment.
4.4.1 Discrete Time Markov Chain Model
p(i+j,a+k),(i,a)(∆t) is the probability that the number of individuals in the infectious
compartment will change from I(t) = i to I(t + ∆t) = i + j and the number of
individuals with acute rheumatic fever will change from A(t) = a to A(t + ∆t) =
a + k over the time step ∆t. The transition probabilities for the SIAS DTMC
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β(N − i− a)i
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Figure 4.4: Flow chart for the SIAS DTMC model showing the transition prob-
abilities for moving between each compartment.
model are
p(i+j,a+k),(i,a)(∆t) =

βi(N − i− a)∆t (j, k) = (1, 0)
γi∆t (j, k) = (−1, 0)
ωi∆t (j, k) = (−1, 1)
κa∆t (j, k) = (0,−1)
1− [βi(N − i− a) + i(γ + ω) + κa]∆t (j, k) = (0, 0)
0 otherwise
(4.9)
These transition probabilities are derived from the differential equations 4.1 seen
earlier in the chapter.
The probability that I = i and A = a at time t + ∆t in terms of the transition
probabilities is given by
p(i,a)(t+ ∆t) = p(i−1,a)(t)β(i− 1)(N − i+ 1− a)∆t
+ p(i+1,a)(t)(γ)(i+ t)∆t+ p(i+1,a−1)(t)ω(i+ 1)∆t (4.10)
+ p(i,a+1)(t)(κ)(a+ 1)∆t
+ p(i,a)(t)(1− [βi(N − i− a) + i(γ + ω) + a(κ)]∆t)
Figure 4.5 shows two sample paths for the transition probabilities in 4.9. The plots
for both Group A streptococcus (I) and acute rheumatic fever (A) are shown along
with their deterministic plots.
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Figure 4.5: Two sample paths of the DTMC SIAS model given in 4.9. The solid
lines are the DTMC sample paths. The dashed lines show the deterministic model.
The lower set of lines is the number of individuals with acute rheumatic fever (A)
and the higher are the number with Group A streptococcus (I). N = 100, β =
0.002, γ = 0.5. ω = 0.2, κ = 0.8
.
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4.4.2 Continuous Time Markov Chain Model
As we said earlier in section 2.5.2, by using a Continuous Time Markov Chain
(CTMC) model, we allow changes to occur over time steps of varying size. A
CTMC model allows us to more accurately represent changes taking place in con-
tinuous time. Because of this increased accuracy, from now on we will only be
using continuous time in our stochastic models.
For the basic SIAS model we can define the CTMC infinitesimal probabilities as
follows
p(i+j,a+k),(i,a)(∆t) =

βi(N−i−a)
N
∆t+ o(∆t) (j, k) = (1, 0)
γi∆t+ o(∆t) (j, k) = (−1, 0)
ωi∆t+ o(∆t) (j, k) = (−1, 1)
κa∆t+ o(∆t) (j, k) = (0,−1)
1− [βi(N−i−a)
N
+ i(γ + ω) + κa]∆t+ o(∆t) (j, k) = (0, 0)
o(∆t) otherwise
(4.11)
Figure 4.6 shows a plot of two sample paths for the SIAS CTMC infinitesimal
transition probabilities. Comparing them with the deterministic plot from the
equations in 4.1 we can see that the sample paths generally follow the deterministic
curve but with some variation induced by the random choice made at each time
step.
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Figure 4.6: Two sample paths of the CTMC SIAS model seen in 4.11. The solid
lines are the CTMC sample paths. The dashed lines show the deterministic model.
The lower set of lines is the number of individuals with acute rheumatic fever (A)
and the higher are the number with Group A streptococcus (I). N = 100, β =
0.02, γ = 0.5. ω = 0.2, κ = 0.8
.
Chapter 5
Developing the Model Further
5.1 Vital Dynamics
Because there is no immunity conferred by Group A streptococcus, if we want to
include the possibility that people may die from acute rheumatic fever, we must
also include natural birth and death rates. Otherwise our whole population would
eventually die out from the disease.
If people die from acute rheumatic fever, there will also be a fraction who recover.
Let f be this fraction that recover, so 1 − f of individuals who develop acute
rheumatic fever will die. In this model the population size will not always be
constant, so N is also changing. Our system of equations for acute rheumatic
fever with vital dynamics is given in 5.1 below:
dS
dt
= bN − βSI + γI + κfA− µS
dI
dt
= βSI − γI − ωI − µI (5.1)
dA
dt
= ωI − κA− µA
We are assuming no vertical transmission of Group A streptococcus from mother
to newborn, so all newborns are born into the susceptible compartment. b is the
birthrate in the population. µ is the natural death rate that would happen in the
54
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κ(1− f)A
Figure 5.1: Flow chart for the SIAS epidemic model with vital dynamics given
by 5.1.
absence of disease. We should note that, since N = S + I + A we can define
dN
dt
= bN − (1− f)κA− µN.
Apart from the addition of a death rate the equations for I and A have not changed
from 4.1. The equation for S gains birth and death rates and κfA replaces κA as
only a fraction f survive having acute rheumatic fever.
5.1.1 Equilibria
dN
dt
= 0 =⇒ (b − µ)N − (1 − f)κA = 0. This means the only way N can reach
an equilibrium where dN
dt
= 0 is if b = µ and f = 1. There are two ways we could
deal with this problem. We could replace bN with b(N) where b(N) is logistic,
so as the population size increases the birth-rate approaches the death-rate so the
population size approaches an equilibrium, also known as the carrying capacity. So
as N approaches this carrying capacity, b(N) approaches µN . While this method
is useful it complicates the system a bit more.
When dealing with the smaller periods of time usually associated with epidemics
we can use the fact that the population will not normally vary in size much. In this
case we can say b ≈ µ and b = µ+ε1, where |ε1|  1. Because of available medical
care in NZ very few individuals actually die from rheumatic fever meaning f is
very close to 1. Most of the deaths are due to Chronic Rheumatic Heart Disease,
which can develop with reccuring episodes of acute rheumatic fever.
Let (1− f)κ = ε2, |ε2|  1. This means
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dN
dt
≈ (µ+ ε1)N − (1− f)κA− µN = ε1N + ε2A.
ε1N > ε2A, So
dN
dt
< 2ε1N .
If we let ε1t = τ ,
dN
dτ
< 2N .
The fact that N is only noticeably changing on the timescale τ = εt, means that
with respect to t we can consider N to be constant and treat it as such in our
analysis.
Treating N = S + I + A as a constant and b ≈ µ we find two equilibrium points.
(S, I) = (N, 0) and
(
γ + ω + µ
β
,
(µ+ κf)(βN − γ + µ+ ω)
β(ω + κf + µ)
)
The Jacobian matrix for this system 5.1 is[
−βI − κf − µ −βS + γ − κf
βI βS − ω − γ − µ
]
(5.2)
At the disease free equilibrium (N, 0), this becomes[
−κf − µ −βN + γ − κf
0 βN − ω − γ − µ
]
(5.3)
This has two eigenvalues −κf − µ and βN − γ − ω − µ. This means the disease
free equilibrium for this system is stable as long as βN < γ + ω + µ.
At the endemic equilibrium the Jacobian matrix becomes
(µ+ κf)(γ + ω + µ− βN)
ω + κf + µ
− κf − µ −ω − µ− κf
(µ+ κf)(βN − γ − µ− ω)
ω + κf + µ
0
 (5.4)
We will find the stability of this point using the trace and determinant. The trace
is
(µ+ κf)(γ + ω + µ− βN)
ω + κf + µ
− κf − µ = (κf + µ)(γ − κf − βN)
ω + κf + µ
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This is negative as long as βN > γ − κf .
The determinant of 5.4 is
(µ+ κf)(βN − γ − µ− ω)
This is positive when βN > γ + µ + ω. So the endemic equilibrium can only be
stable when the disease free equilibrium is unstable. Again we see an example
of transcritical bifurcation. The endemic equilibrium is stable as long as βN >
γ + ω + µ.
5.2 Stochastic Model with Vital Dynamics
Using our rheumatic fever model with vital dynamics from 5.1, with b = µN , we
can derive a set of transition probabilities for the CTMC SIAS model with vital
dynamics. Using S = N − A − I the probabilities of each single change of state
are as follows
p(i+j,a+k),(i,a)(∆t) =

βi(N − i− a)∆t+ o(∆t) (j, k) = (1, 0) S → I
(γ + µ)i∆t+ o(∆t) (j, k) = (−1, 0) I → S
ωi∆t+ o(∆t) (j, k) = (−1, 1) I → A
(µ+ κ)a∆t+ o(∆t) (j, k) = (0,−1) A→ S
1− [βi(N − i− a) + i(γ + ω + µ) + a(κ+ µ)]∆t+ o(∆t) (j, k) = (0, 0) No Change
o(∆t) otherwise
(5.5)
µi and µa represent the birth of a susceptible being balanced by the death of an
infected or an individual with acute rheumatic fever, respectively.
The probability that I = i and A = a at time t + ∆t in terms of the transition
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Figure 5.2: Two sample paths of the CTMC SIAS model given by the transition
probabilities in 5.5. The solid lines are the CTMC sample paths. The dashed lines
show the deterministic model. The lower set of lines is the number of individuals
with acute rheumatic fever (A) and the higher are the number with Group A
streptococcus (I). N = 100, β = 0.02, µ = 0.1, γ = 0.5. ω = 0.2, κ = 0.8
.
probabilities is given by
p(i,a)(t+ ∆t) = p(i−1,a)(t)β(i− 1)(N − i+ 1− a)∆t
+ p(i+1,a)(t)(γ + µ)(i+ t)∆t+ p(i+1,a−1)(t)ω(i+ 1)∆t (5.6)
+ p(i,a+1)(t)(κ+ µ)(a+ 1)∆t
+ p(i,a)(t)(1− [βi(N − i− a) + i(γ + ω + µ) + a(κ+ µ)]∆t)
A plot of two sample paths, using these transition probabilities is shown in Figure
5.2. Matlab was used to create this plot
Basically we use a random number between 0 and 1 to pick which type of change
occurs in each time step. The size of each time step is randomly chosen on an
exponential distribution as was discussed in section 4.4.2. The code for this is in
the appendix.
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Figure 5.3: Flow chart for the SIAS epidemic model with migration and vital
dynamics, given in 5.7.
5.3 Migration
In New Zealand, migration can be an important factor. Immigration must be rep-
resented slightly differently from births, as individuals could possibly be infected
with Group A streptococcus or have acute rheumatic fever when they migrate.
This means we need three separate ‘birth terms’. Let b1S + b2I + b3A = bN be
the total rate of inflow into the population due to births and immigration. b1 is
a combination of susceptible immigrants and births of children, b2 represents im-
migration of infected individuals and b3 represents the immigration of individuals
with acute rheumatic fever. Now µ represents deaths and emigration. This gives
us a modified system of equations
dS
dt
= b1S − βSI + γI + κfA− µS
dI
dt
= b2I + βSI − γI − ωI − µI (5.7)
dA
dt
= b3A+ ωI − κA− µA
(5.8)
and consequentially,
dN
dt
= bN − (1− f)κA− µN
This modification to the equations alters the flow chart by having entry into each
compartment via immigration. This is shown in Figure 5.3.
Using the argument in section 5.1.1 above, we will treat the population size N ,
as a constant. This means we can again reduce our system so we are just dealing
CHAPTER 5. DEVELOPING THE MODEL FURTHER 60
with I and S.
The Jacobian matrix we then get is[
b1 − βI − κf − µ −βS + γ − κf
βI b2 + βS − ω − γ − µ
]
(5.9)
Setting the equations in 5.7 equal to 0 we get I = 0 or βS = ω + γ + µ− b2.
I = 0 gives us the disease free equilibrium
S =
κfN
κf + µ− b1
Substituting this into the Jacobian matrix (5.9) we get
b1 − κf − µ − βκfN
κf + µ− b1 + γ − κf
0 b2 +
βκfN
κF + µ− b1 − ω − γ − µ
 (5.10)
which has eigenvalues b1 − κf − µ and b2 + βκfNκf+µ−b1 − ω − γ − µ. These are both
negative if
b1 < κf + µ and βN <
(κf + µ− b1)(ω + γ + µ− b2)
κf
βN > 0 always, so for the second condition to be true, the righthand side of the
inequality must also be positive. The first condition means κf + µ− b1 > 0 so we
need ω+ γ+µ > b2. Under these conditions the disease free equilibrium is stable.
The endemic equilibrium exists at βS = ω + γ + µ− b2 and
βI =
βκfN − (κf + µ− b1)(ω + γ + µ− b2)
ω + µ+ κf − b2
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The Jacobian matrix at the endemic equilibrium then becomes
(κf − γ)(b1 − κf − µ)− βκfN
ω + µ+ κf − b2 −ω − µ+ b2 − κf
βκfN − (κf + µ− b1)(ω + γ + µ− b2)
ω + µ+ κf − b2 0
 (5.11)
The determinant of the Jacobian matrix 5.11 is
βκfN − (κf + µ− b1)(ω + γ + µ− b2)
This is positive if
βκfN > (κf + µ− b1)(ω + γ + µ− b2)
The trace of 5.11 is
(κf − γ)(b1 − κf − µ)− βκfN
ω + µ+ κf − b2
which is negative if
βκfN > (κf − γ)(b1 − κf − µ)
Because the endemic equilibrium exists at βS = ω + γ + µ − b2, we need βN ≥
ω + γ + µ − b2 for this equilibrium point to be valid (All compartments contain
non-negative numbers of individuals). So for the endemic equilibrium to be both
valid and stable we need
βN >
(κf + µ− b1)(ω + γ + µ− b2)
κf
≥ ω + γ + µ− b2
Which implies
κf + µ− b1
κf
≥ 1
κf + µ− b1 ≥ κf
µ− b1 ≥ 0
µ ≥ b1
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This makes sense under the assumption that N is approximately constant and
µN ≈ bN = b1S + b2I + b3A. We are also assuming κf + ω + 2γ + µ > b2 though
this seems to be a reasonable assumption given all our parameters are positive and
b2, which is the rate of infected people entering the population, is likely to be quite
small.
5.3.1 Independence of Immigration
In the above system 5.7, rates of migration and births into and from each com-
partment are represented as proportional to the number of individuals currently
in that compartment. This makes sense for deaths and emigration, as the number
of people available to leave a compartment would be dependent on how many are
in that compartment. For births and immigration however, it makes more sense
for the number for people entering to be dependent on the whole population size,
or even independent of any other value. Infected individuals and individuals with
acute rheumatic fever will not immigrate based on how many other individuals
are infected or have acute rheumatic fever, it is much more likely to depend on
the total population size. Although this still may not be true in New Zealand
where immigration is regulated, it may also be more dependent on the size of the
global population. Taking this into account we can modify the equations to get
this system.
dS
dt
= b1N − βSI + γI + κfA− µS
dI
dt
= b2N + βSI − γI − ωI − µI (5.12)
dA
dt
= b3N + ωI − κA− µA
The rates of immigration into each compartment are now all proportional to N in-
stead of each individual compartment size. the differential equation for N remains
the same as in 5.7. Figure 5.4 shows the modification to the flow chart.
Using the same argument as above in section 5.1, we will treat the population
size, N , as a constant. This means we can again reduce our system so we are just
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Figure 5.4: Flow chart for the SIAS epidemic model with immigration propor-
tional to total population size as given in 5.12 .
dealing with I and S. The Jacobian matrix we then get is[
−βI − κf − µ −βS + γ − κf
βI βS − ω − γ − µ
]
(5.13)
Setting the equations in the system equal to 0 we get
S =
(γ + µ+ ω)I − b2N
βI
I =
βN + γ + ω + µ±
√
(βN + γ + ω + µ)2 − 4βb2N( ωκ+µ + 1)
2β( ω
κ+µ
+ 1)
These are both the endemic equilibria. Because there is always the possibility of
infected persons entering the population via immigration there is no disease free
equilibrium.
5.4 Exposed Periods and Treatment Models
In this section we will be deviating briefly from acute rheumatic fever modelling
and focusing more generally on SIR type models. Not everything mentioned in
this section relates explicitly to acute rheumatic fever, but there are important
concepts here that we need to consider. We will discuss the use of these concepts
in the later development of our SIAS model in Chapter 6.
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5.4.1 Exposed Periods
Many infectious diseases have a latent period, where an individual has been ex-
posed to the disease and is infected, but is not yet infectious. The length of this
exposed period has little effect on the predictions of an epidemic model [7]. To
incorporate an exposed period into an SIR type model, we add the compartment
E. With a mean exposed period of 1/v this gives us the SEIR model below:
dS
dt
= −βSI
dE
dt
= βSI − vE (5.14)
dI
dt
= vE − γI
dN
dt
= −(1− f)γI
We have used the equation for N instead of R as it shows our inclusion of the
possibility for death from the disease better. The equation for R is R′ = γfI as
not all infectious individuals recover.
In some diseases, this exposed period is really an asymptomatic stage of infec-
tiousness, where there is some infectiousness but it is reduced by some factor εE
until the individual moves into the fully infectious compartment. In this case the
equations for S and E become
S ′ = −βS(I + εEE) (5.15)
E ′ = βS(I + εEE)− vE
The equations for I and N remain the same as in 5.14 [7]. For this model R0 is
the sum of the secondary infections caused by an individual in a fully susceptible
population, during their exposed period and during their infectious period.
R0 = βN
γ
+ εE
βN
κ
(5.16)
Though we will not be using exposed periods in the acute rheumatic fever model we
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develop in this thesis, the concept of more that one compartment being infectious
is important [7]. We will use multiple infectious compartments later on along
with the idea that R0 is the sum of all the secondary infections caused by each
compartment.
5.4.2 Vaccination models
For many diseases, there are vaccinations to protect against infection. This is one
form of treatment, and a simple way of accounting for it is to reduce the population
size by the number of vaccinated individuals. In reality however vaccinations
may only reduce the rate of infection. Along with other treatments however,
they may reduce the infectiousness of a vaccinated individual if they do become
infected [7]. Modelling this requires an extra compartment similar to the exposed
compartment in section 5.4.1 above. In the case of vaccination however, vaccinated
individuals follow a path parallel to other individuals. Not everyone goes though
the compartment of reduced infectiousness.
The main issue with modelling this separation is identifying who has been vacci-
nated prior to becoming infected. What this may require is multiple compartments
for susceptible individuals. This will keep vaccinated individuals separate from the
rest of the population in the model so we can deal with their interactions in the
population separately.
If we use the subscript V to identify vaccinated individuals, the flow chart for an
SIR model with vaccination might look like the diagram shown in Figure 5.5.
Once an individual is recovered from the infection, with immunity, their previous
vaccination status is no longer important to the model.
We have not included vital dynamics in this model. The main point of its in-
troduction is to show the use of multiple susceptible compartments and parallel
infection and recovery paths. The differential equations that match the diagram
in Figure 5.5 are
dS
dt
= −βS(I + εIV )− λS dSV
dt
= λS − κSV (I + εIV )
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Figure 5.5: A flow chart for the SIR model with vaccination. κ represents the
reduced susceptibility of vaccinated individuals. ε is the factor by which their
infectiousness is reduced. λ is the rate of vaccination.
dI
dt
= βS(I + εIV )− γI dIV
dt
= κSV (I + εIV )− αIV (5.17)
dR
dt
= γI + αIV
Though it may be unrealistic, this model assumes that the vaccination lasts life-
time. this is purely to provide a simple introduction to this type of model, a more
complicated model could be constructed to account for vaccination wearing off
over time, but is beyond the scope of this thesis. We are also assuming mixing in
the population is independent of vaccination status. This means any susceptible
individual, vaccinated or not, can be infected by any infectious individual. R0
is the sum of the number of new infections due to each infectious compartment.
It is the rate of transfer of individuals into that compartment multiplied by the
rate at which they leave. If we let I + IV = It be the total number of infectious
individuals, the part of R0 due to I is as follows
βSIt
βSIt + κSV It
× βSI + κSV I
γI
=
βS
γ
βSIt is the portion of individuals being infected who move into compartment I.
βSI + κSV I is Th rate of infection due to individuals in compartment I, and γI i
the rate that they leave I.
Doing the same thing for compartment IV we get
κSV It
βSIt + κSV It
× βSεIV + κSV εIV
αIV
= ε
κSV
α
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This gives us
R0 = βS
γ
+ ε
κSV
α
The ε is the factor by which infectiousness of vaccinated is reduced.
There is currently no vaccination against Group A streptococcus, available for
widespread use [12]. Because of this we will not use a vaccination compartment
in our further development of the model for acute rheumatic fever. Both Group
A streptococcus and acute rheumatic fever however are diseases that have shown
increased prevalence among certain age groups [4] and in New Zealand, different
ethnicities show variation [18][11]. This is an area where we may need to use
multiple susceptible compartments to account for the different rates of infection
for different demographics.
5.4.3 Treatment for infection
In the situation where there is a treatment for the disease after an individual has
been infected, we can use an SITR model, where T is the compartment containing
those undergoing treatment. Suppose some fraction α of infected individuals are
selected for treatment per unit of time, the treatment reduces infectivity by a
fraction δ and the rate of removal of treated individuals is η. [7]. The model we
then produce is
dS
dt
= −βS(I + δT )
dI
dT
= βS(I + δT )− (γ + α)I (5.18)
dT
dt
= αI − ηT
dR
dt
= γI + ηT
The flow chart for this model is shown in Figure 5.6
The mean amount of time spent in the infective compartment is 1/(γ + α) so an
individual in this compartment would cause βN/(γ + α) secondary infections, in
a fully susceptible population. The fraction α/(γ + α) of infected individuals are
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Figure 5.6: A flow chart for the SIR model with treatment as seen in 5.18. δ is
the factor by which infectiousness is reduced for individuals in treatment. α is the
rate of treatment. γ and η represent the different rates of recovery.
treated. While in the treatment compartment an individual will cause δβN new
infections per unit of time. Individuals remain in the treatment class for a mean
time of 1/η so the number of secondary infections caused by treated individuals,
in a fully suscpetible population, is α/(γ + α)× δβN/η [7]. Overall R0 is
R0 = βN
γ + α
+
αδβN
η(γ + α)
(5.19)
5.5 Acute Rheumatic Fever History
An individual’s history in relation to acute rheumatic fever will affect their likeli-
hood of developing the disease following their next Group A streptococcus infec-
tion. An individual who has had acute rheumatic fever before is more at risk than
someone who has not [1]. This is something we should account for in our model.
Similarly to how the population was split in section 5.4.2 based on vaccination
status, we can split the population based on individual history in relation to acute
rheumatic fever. We assume that an individual’s history of acute rheumatic fever
only affects their susceptibility to acute rheumatic fever and not their susceptibility
or infectiousness in relation to Group A streptococcus. Figure 5.7 shows what the
flow of individuals would look like in a model accounting for acute rheumatic fever
history.
The subscript A represents those individuals who have had Acute Rheumatic fever
in the past. These individuals have a greater chance of developing acute rheumatic
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Figure 5.7: Flow chart for an acute rheumatic fever model with compartments for
individuals with a history of Rheumatic fever.
fever, so σ > ω. It is also logical that they would have a reduced chance of recov-
ering from a Group A streptococcus infection without developing acute rheumatic
fever, therefore χ < γ. The differential equations for the model shown in Figure
5.7 are given in 5.20 below
dS
dt
= −βS(I + IA) + γI dSA
dt
= κA− βSA(I + IA) + χIA
dI
dt
= βS(I + IA)− γI − ωI dIA
dt
= βSA(I + IA)− χIA − σIA (5.20)
dA
dt
= ωI + σIA − κA
One big issue with this model is that all individuals flow towards eventually hav-
ing acute rheumatic fever. S gets replenished by those who recover from Group A
streptococcus without developing acute rheumatic fever. Some individuals how-
ever, are always lost to the right hand side of the diagram in Figure 5.7. Eventually
there will be no one left without a history of acute rheumatic fever. We can see
this in the equilibrium points as well.
The differential equations in 5.20 give us two equilibrium points. The disease free
equilibrium occurs when
I = A = IA = 0 =⇒ S + SA = N
It is realistic for individuals to settle into the two susceptible compartments once
the disease dies out and can theoretically occur at any value of S or SA.
The other endemic equilibrium however, can only be reached once we run out of
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Figure 5.8: Flow chart for an acute rheumatic fever model with compartments for
individuals with a history of acute rheumatic fever and vital dynamics.
individuals who have never had acute rheumatic fever. This happens when
S = I = 0, SA =
χ+ σ
β
, IA =
κ(χ+ σ)
β(κ+ σ)
and A =
σ(χ+ σ)
β(κ+ σ)
This is an unrealistic equilibrium, especially in a population where not everyone
is actually susceptible to developing acute rheumatic fever.
A model that is unrealistic is not much use in the real world. We need to do
something about the fact that we are running out of susceptible individuals with
no history of acute rheumatic fever. One way to balance this loss is by introducing
new individuals in the form of newborns. This means we need to include vital
dynamics in the model.
5.5.1 History with Vital Dynamics
By including vital dynamics we can replenish the susceptible compartment con-
taining those with no history of acute rheumatic fever. Figure 5.8 shows the flow
of individuals once we add in the vital dynamics.
The introduction of vital dynamics also allows us to include the possibility that
individuals might die from acute rheumatic fever. The system of differential equa-
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tions when we include vital dynamics and disease deaths is as follows:
dS
dt
= bN − βS(I + IA) + γI − µS
dI
dt
= βS(I + IA)− γI − ωI − µI
dA
dt
= ωI + σIA − κA− µA (5.21)
dSA
dt
= κfA− βSA(I + IA) + χIA − µSA
dIA
dt
= βSA(I + IA)− χIA − σIA − µIA
where b is the birth rate. µ is the death rate and (1 − f) is the proportion
of individuals that die from acute rheumatic fever. If we let b ≈ µ as per the
argument in section 5.1.1 we can find the equilibrium points. The equations in
5.21 give us three equilibrium points. The disease free equilibrium occurs when
S = N, and I = A = SA = IA = 0
This describes the situation where Group A streptococcus has died out in the
population before anyone has developed acute rheumatic fever and survived it. Or
everyone with a history of acute rheumatic fever has died out.
If f 6= 1 The endemic equilibrium we find is
S = −σ(γ + ω + µ)
β(ω − σ) SA =
ω(χ+ σ + µ)
β(ω − σ)
I =
σµ(σ + χ+ µ)
β(ωµ− σ(σ + ω + µ)) IA = −
ωµ(σ + χ+ µ)
β(ωµ− σ(σ + ω + µ))
A = 0
Even though f 6= 1, none of these equations depend on f , because κf is the
coefficient of A and A = 0 at this equilibrium.
This equilibrium however is not valid. If all of the compartments and parameters
are non-negative, S and SA and I and IA cannot validly exist at the same time.
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For S to be valid we need
S = −σ(γ + ω + µ)
β(ω − σ) ≥ 0, ω 6= σ
β(ω − σ) < 0
ω < σ
However for SA to be valid we require that ω > σ, the opposite. The only way
this point could be valid is if σ = 0. The equilibrium point would then become
S = I = A = 0, and SA = IA =
χ+ µ
β
Which like the equilibrium point in section 5.5 above is unrealistic and acutally
impossible if µ > 0. So this model has no realistic endemic equilibrium unless,
under the assumption µ ≈ b, the assumption that f ≈ 1 is also made .
The running reproduction number for this model is
R∗ βS
γ + ω + µ
+
βSA
χ+ σ + µ
(5.22)
For the numerical solution 5.9 If we assumed the outbreak started in a fully suscep-
tible population with no history of acute rheumatic fever, then basic reproduction
number would be
R0 = βN
γ + ω + µ
(5.23)
Figure 5.9 shows a plot a numerical solution produced by this model. In this
particular plot R0 = 3.85. The number of infected individuals shoots up steeply
then begins to settle down to what looks like an endemic equilibrium.
By assuming f = 1 we get three equilibrium points, one of which is the disease
free equilibrium given above. The other two equilibrium points points, are endemic
equilibria. They are solutions of cubic which we will not show here. The numbers
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Figure 5.9: A plot of numerical solutions for acute rheumatic fever history model
given in 5.21. The dashed, green line represents total Group A streptococcus
numbers, both compartment I and IA added together. The solid line plots the
acute rheumatic fever (A) numbers. N = 100, β = 0.02, µ = 0.01, γ = 0.5. ω =
0.02, κ = 0.8, χ = 0.4, σ = 0.5.
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in each compartment in terms of S however are;
I =
µ(N − S)
ω + µ
IA =
µ(S −N)(βS − γ − ω − µ)
βS(ω + µ)
A =
µ(N − S)(ωβS − σ(βS − γ − ω − µ))
βS(ω + µ)(κ+ µ)
SA =
βS(χ+ σ + ω)(ω + γ + µ− βS)
ω + γ + µ
If we use R∗ = 1 at an endemic equilibrium we can find the values of S at the
equilibrium points from equation 5.22.
R∗ = βS
γ + ω + µ
+
βS(χ+ σ + ω)(γ + ω + µ− βS)
(γ + ω + µ)(χ+ σ + µ)
= 1
βS + βS(γ + ω + µ)− (βS)2
γ + ω + µ
= 1
βS(βS − 1)− (γ + ω + µ)(βS − 1) = 0
(βS − (γ + ω + µ))(βS − 1) = 0
⇒ βS = γ + ω + µ or βS = 1.
Chapter 6
A New Zealand Specific Model
In New Zealand, acute rheumatic fever is a notifiable disease. This means that
if an individual is diagnosed with acute rheumatic fever, the medical practitioner
involved must report it [18, 22]. Because of this requirement data for rates of acute
rheumatic fever in New Zealand are fairly good.
To construct a model that follows the behaviour of acute rheumatic fever in New
Zealand accurately, we need to take into account aspects of the disease’s behaviour
that are specific to New Zealand.
There is a strong ethnic association with acute rheumatic fever in New Zealand.
Maori and Pacific Island peoples have an increased risk of developing the disease
following a Group A streptococcus infection. Rates also seem to vary geographi-
cally within the country [18]. It is not clear if this geographical variation is due to
the distribution of ethnicities in the country, or if the increased incidence among
particular ethnicities is due to higher rates in different geographical locations. It
is possible it could be a mix of both variables. Even if we are not sure of the cause,
these factors should be taken into account in our model.
Age is also a factor in an individual’s risk levels. While it is not specific to New
Zealand it is an important factor that we need to account for in the construction
of our model.
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CHAPTER 6. A NEW ZEALAND SPECIFIC MODEL 76
6.1 Public Health records and treatment
Because acute rheumatic fever is a notifiable disease in New Zealand, and because
of good public health records, anyone who has had acute rheumatic fever once
will be treated differently in the future in relation to Group A streptococcus and
acute rheumatic fever symptoms. This means that as people recover from an
episode of acute rheumatic fever, we cannot just put them back into the susceptible
population with everyone else. We need to add extra compartments to the model
for individuals with a history of acute rheumatic fever, as we did in section 5.5.
The effective treatment of Group A streptococcus will prevent the development of
acute rheumatic fever [24]. When we include treatment classes in our model, we
allow the assumption that individuals who receive treatment for Group A strep-
tococcus will not go on to develop acute rheumatic fever. We can also assume
that individuals with a known history of acute rheumatic fever will always seek
treatment for a Group A streptococcus infection.
If we start with a simple model without any vital dynamics we produce the fol-
lowing system of equations.
dS
dt
= −βS(I + IA) + γI + ρT
dI
dt
= βS(I + IA)− γI − φI − ωI
dT
dt
= φI − ρT
dA
dt
= ωI − ηA (6.1)
SA
dt
= ηA+ λTA − βSA(I + IA)
dIA
dt
= βSA(I + IA)− σIA
dTA
dt
= σIA − λTA
TA, SA, and IA represent individuals who have been through the acute rheumatic
fever compartment and are now in treatment, susceptible or infected with Group
A streptococcus respectively. Figure 6.1 shows the flow of individuals for this
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Figure 6.1: Flow of individuals in an acute rheumatic fever treatment model with
compartments for individuals with a history of acute rheumatic fever, as modelled
by the equations in 6.1.
system.
Because of the way we have set up the rate of transfer between compartments,
once an individual has gone through the acute rheumatic fever compartment they
cannot go back to being a ‘normal’ susceptible. This causes a bit of a problem
though because eventually everyone in the population is going to go through the
acute rheumatic fever compartment as we have set up no alternative route. This
is similar to what we saw in section 5.5 for the system 5.20.
We get two possible equilibrium points for this model. The disease free equilibrium
is at (S, I, T, A, SA, IA, TA) = (S, 0, 0, 0, N−S, 0, 0) where the disease dies out, this
can happen at any point in time during the epidemic. This equilibrium is stable
as long as βN < σ.
This model also has an endemic equilibrium at
(S, I, I, A, SA, IA, TA) =
(
0, 0, 0, 0,
σ
β
,
σ(βN − σ)
βλ(λ+ 1)
,
βN − σ
β(λ+ 1)
)
The Jacobian for this equilibrium has a determinant of 0 and the trace is
−2λ(βN − σ)
σ − λ − η − φ− ρ− ω − λ− γ
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This means this equilibrium point is stable as long as
2λ(βN − σ)
σ − λ > 0
So either
βN > σ > λ or λ > σ > βN
This equilibrium seems rather unrealistic, especially when we know that not every-
one will develop acute rheumatic fever after contracting Group A streptococcus,
even if they have multiple Group A streptococcus infections [11]. To solve this
problem we need to allow for people to recover from Group A streptococcus and
never develop acute rheumatic fever, introducing vital dynamics could help here.
6.1.1 Vital dynamics model
Including vital dynamics in the model allows us to bring new susceptible individ-
uals into the population via births. At the same time individuals with a history
of acute rheumatic fever may leave the population via deaths. If we assume ‘birth
rate’ = ‘death rate’=µ, the new system of equations we get is
dS
dt
= µN − βS(I + IA) + γI + ρT − µS
dI
dt
= βS(I + IA)− γI − φI − ωI − µI
dT
dt
= φI − ρT − µT
dA
dt
= ωI − ηA− µA (6.2)
dSA
dt
= ηA+ λTA − βSA(I + IA)− µSA
dIA
dt
= βSA(I + IA)− σIA − µIA
dTA
dt
= σIA − λTA − µTA
One of these equations is redundant, if we let TA = N − (S+ I +T +A+SA + IA)
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Figure 6.2: Flow chart for an acute rheumatic fever treatment model with vital
dynamics and compartments for individuals with a history of acute rheumatic
fever.
we get the jacobian matrix

−β(I + IA)− µ −βS + γ ρ 0 0 −βS
β(I + IA) βS − µ− φ− ω − γ 0 0 0 βS
0 φ −µ− ρ 0 0 0
0 ω 0 −µ− η 0 0
−λ −βSA − λ −λ η − λ −β(I + IA)− λ− µ −βSA − λ
0 βSA 0 0 β(I + IA) βSA − µ− σ

(6.3)
A diagram showing the flow of individuals for this model is shown in Figure 6.2.
In this case, as most acute rheumatic fever deaths are due to recurrent attacks
that lead to rheumatic heart disease [12], we have simplified the model by assum-
ing there are no deaths due to the disease. Because of the way we have designed
the model, individuals with a history of acute rheumatic fever always receive treat-
ment for a Group A streptococcus infection. They therefore never develop acute
rheumatic fever again. We have essentially eliminated the possibility of recurrent
attacks in individuals with a known history of acute rheumatic fever. We are also
assuming that births equal deaths so our population size N is constant.
Using Sage [30] we were able to find two equilibrium points for this model. The
disease free equilibrium at;
S = N, and I = T = A = SA = IA = TA = 0
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This is similar to what we saw in section 5.5.1. The disease free equilibrium point
represents a population where Group A streptococcus has died out before anyone
has developed acute rheumatic fever. Because we have included vital dynamics
in this model, it is also possible there were individuals who had acute rheumatic
fever, but all these compartments have died out.
The Jacobian matrix in the case of the disease free equilibrium becomes
0 −βN + b+ ρ+ γ µ µ µ −βN + µ µ
0 βN − µ− φ− ω − γ 0 0 0 βN 0
0 φ −µ− ρ 0 0 0 0
0 ω 0 −b− η 0 0 0
0 0 0 η −µ 0 λ
0 0 0 0 0 −µ− σ 0
0 0 0 0 0 σ −µ− λ

(6.4)
This equilibrium point is stable as long as βN < µ+ φ+ ω + γ.
Analytically there is another equilibrium point at
S = I = A = 0 SA =
σ + µ
β
(6.5)
IA = −(λ+ µ)(σ + µ)
β(λ+ σ + µ)
TA = − σ(σ + µ)
β(λ+ σ + µ)
This point immediately appears unrealistic and it is. Much like the endemic equi-
librium point in section 5.5, it is unrealistic for the whole population to develop
rheumatic fever.
This point is also not valid. The compartment sizes cancel each other out by all
adding to 0 instead of N , and both IA and TA have negative values. For a bio-
logically realistic model all compartments must be non-negative in size. Therefore
this model also has no valid endemic equilibrium.
The basic reproduction number for this model, R0 is
R0 = βN
µ+ φ+ γ + ω
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Figure 6.3: Numerical solution for the model given in 6.2. Group A streptococcus
(I+IA) is represented by the solid line and acute rheumatic fever (A) numbers are
given by the dashed line. R0 < 1. The initial number of infections was 2. N=400,
β = 0.00055, µ = 0.01, φ = 0.1, ω = 0.03, γ = 0.1, σ = 0.8
as time goes on and individuals develop acute rheumatic fever, moving into the
right hand side of the model, our effective reproduction number becomes
R∗ = βS
µ+ φ+ γ + ω
+
βSA
µ+ σ
,
as infectious individuals with a history of acute rheumatic fever also effect the rate
of infection.
When R0 < 1, βN < µ + φ + ω + γ. The disease dies out as expected and
we reach the disease free equilibrium, I = IA = 0. Figure 6.3 shows how the
number of infectious individuals quickly dies out in this scenario and the number
of individuals with acute rheumatic fever follows closely.
There is an initial bump in the number of individuals with acute rheumatic fever
as a proportion of those infected with Group A streptococcus before it dies out,
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Figure 6.4: Plot of the reproduction number with R0 < 1, using numerical
solutions to the model given in 6.2. The same parameters as used in Figure 6.3
apply.
still develop acute rheumatic fever.
With the parameters, used for the plot in Figure 6.3, R0 = 0.914 < 1. As some
individuals are infected and develop acute rheumatic fever initially the effective re-
production number drops with the falling number of susceptible. Once individuals
start to recover faster than they are being infected, the reproduction number starts
to increase. The disease continues to die out however because there are no infec-
tious individuals left to infect anyone and R∗ < 1 still. The effective reproduction
number settles at R0. This behaviour is shown in Figure 6.4.
We were unable to find a realistic endemic equilibrium easily earlier. So what does
happen when βN > b+ω+γ+φ? Figure 6.5 shows a plot for βN > µ+φ+ω+γ
and R0 > 1.
The number of infected individuals shoots up steeply near the start but then drops
off almost as steeply to settle into an equilibrium. The number of individuals with
acute rheumatic fever does the same thing but not quite so steeply.
The effective reproduction number drops off sharply near the beginning, and actu-
ally drops below one twice before settling there in an equilibrium. This is shown
in Figure 6.6. From these Figures 6.3, 6.4, 6.5 and 6.6, we can see the disease free
equilibrium is reached when R∗ = R0 and the endemic equilibrium when R∗ = 1.
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Figure 6.5: Group A streptococcus and acute rheumatic fever numbers, given by
numerical solutions to the model seen in 6.2. R0 > 1. The dashed line represents
rheumatic fever and the solid line gives Group A streptococcus numbers. The
initial number of infectious was 2. N=400, β = 0.0009, µ = 0.01, φ = 0.1, ω =
0.03, γ = 0.1, σ = 0.8
Figure 6.6: Plot of the running reproduction number for R0 > 1, using numerical
soulutions to the model given in 6.2. The same parameters as used in Figure 6.5
apply.
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i j Probability Change in i Change in j
S I βS(I + IA)∆t+ o(∆t) s −→ s− 1 i −→ i+ 1
I S (γ + µ)I∆t+ o(∆t) i −→ i− 1 s −→ s+ 1
I T φI∆t+ o(∆t) i −→ i− 1 τ −→ τ + 1
T S (ρ+ µ)T∆t+ o(∆t) τ −→ τ − 1 s −→ s+1
I A ωI∆t+ o(∆t) i −→ i− 1 a −→ a+ 1
A S µA∆t+ o(∆t) a −→ a− 1 s −→ s+ 1
A SA ηA∆t+ o(∆t) a −→ a− 1 sA −→ sA + 1
TA S µTA∆t+ o(∆t) τA −→ τA − 1 s −→ s+ 1
TA SA λTA∆t+ o(∆t) τA −→ τA − 1 sA −→ sA + 1
SA S µSA∆t+ o(∆t) sA −→ sA − 1 s −→ s+ 1
SA IA βSA(I + IA)∆t+ o(∆t) sA −→ sA − 1 iA −→ iA + 1
IA S µIA∆t+ o(∆t) iA −→ iA − 1 s −→ s+ 1
IA TA σIA∆t+ o(∆t) iA −→ iA − 1 τA −→ τA + 1
Table 6.1: Transition probabilities for transition of individuals from compartment
i to j. The probability that nothing changes is one minus, the sum of all the above
probabilities.
So we can confirm the presence of the endemic equilibrium by plotting a numerical
solution, and estimate when it will happen using the running reproduction number
R∗. The question stability is still unanswered.
6.1.2 Stochastic Model
We can easily derive a CTMC Model incorporating individual acute rheumatic
fever history, treatment and vital dynamics.
Using a stochastic model allows us to incorporate chance into the model. We can
essentially account for unknown factors and influences on the patterns of disease
spread. The stochastic variation allows for a more accurate prediction of what
might actually happen without the need to complicate the actual model further.
The table of transition probabilities is shown in Table 6.1 Using these transition
probabilities and the same parameters as we did for the deterministic model we can
plot sample paths. Figure 6.7 shows two sample paths for the stochastic model,
plotted along with the deterministic model.
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Figure 6.7: CTMC plot using the transition probabilities given in table 6.1. The
parameter values are the same as those used to produce the plot in figure 6.5.
The dashed lines show the deterministic model. ‘I’ is the number of individuals
infected with Group A streptococcus, ‘A’ is the number of indiviuals suffering from
acute rheumatic fever.
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The stochastic model tends to oscillate a lot. In one of the simulations, Group
A streptococcus died out just before 200 days, even though the deterministic plot
shows the disease settling to an equilibrium. This is an example of a the disease
can die out at anytime in the stochastic model no matter what the deterministic
model predicts should happen. It also suggests that the endemic equilibrium may
not be stable.
6.2 Including Demographics
The risks of both contracting Group A streptococcus and developing acute
rheumatic fever change with age and vary due to ethnicity and geographic lo-
cation. Because of this variation we need to take these demographics into account
when constructing our model. Individuals of different ages and ethnicities need to
be separated in the model so we can account for their differing rates of developing
acute rheumatic fever. A simple variation of the SIAS model that accounts for
ethnicity is shown below:
dSM
dt
= −βSM(IM + IE) + γIM + κAM
dIM
dt
= βSM(IM + IE)− γIM − ωIM
dAM
dt
= ωIM − κAM (6.6)
dSE
dt
= −βSE(IM + IE) + γIE + κAE
dIE
dt
= βSE(IM + IE)− γIE − αIE
dAE
dt
= αIE − κAE
The M and E subscripts denote Maori & Pacific Island peoples and other ethnicities
respectively. ω and α represent the different rates of developing acute rheumatic
fever for Maori and Pacific peoples and the other ethnicities. There is no movement
of individuals between ethnic subgroups. Assuming homogeneous mixing however,
infectious individuals of any ethnicity can infect any susceptible individual at the
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Figure 6.8: Flow chart for an acute rheumatic fever model including ethnicity,
given by the equations in 6.6.
same rate regardless of ethnicity. In reality homogeneous mixing may not be
realistic and some type of proportional or preferential mixing maybe more suitable.
This adds further complication to the construction of the model however an is
outside the scope of this thesis. Figure 6.8 illustrates the flow of individuals for
this model.
Analytically there are three equilibrium points for this model. The disease free
equilibrium is at
SM + SE = N, IM = AM = IE = AE = 0
In this case, because we have not included acute rheumatic fever history in the
model, the disease has just died out at some point and everyone has gone back to
being susceptible. An individual’s ethnicity does not change so we have SM = NM
and SE = NE where NM and NE are the constant population sizes for each ethnic
group.
Because one of the equations in the system 6.6 is redundant, we can use AE =
N − (SM + IM +AM +SE + IE), the Jacobian matrix for this is given below in 6.7
−β(IM + IE) −βSM + γ κ 0 −βSM
β(IM + IE) βSM − γ − ω 0 0 βSM
0 ω −κ 0 0
−κ −βSE − κ −κ −β(IM + IE)− κ −βSE + γ − κ
0 βSE 0 β(IM + IE) βSE − γ − α
 (6.7)
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The Jacobian matrix at the disease free equilibrium becomes
0 −βNM + γ κ 0 −βNM
0 βNM − γ − ω 0 0 βNM
0 ω −κ 0 0
−κ −βNE − κ −κ −κ −βNE + γ − κ
0 βNE 0 0 βNE − γ − α
 (6.8)
The trace of this matrix is βN − 2γ − ω − α − 2κ, and the determinant is 0. So
the disease free equilibrium is stable as long as βN < α + 2(γ + κ) + ω.
There is an endemic equilibrium at
SM =
(γ + ω)IM
β(IM + IE)
, IM =
βNM(α + γ)− (γ + ω)(α + γ − β(NM − IE(1 + ακ )))
β(α + γ)(1 + ω
κ
)
,
AM =
ωIM
κ
, SE =
(α + γ)
(
1− IM
IM+IE
)
β
,
IE = IM
(
γ + ω
β(NM − IM(1 + ωκ ))
− 1
)
, AE =
αIE
κ
We also get a third equilibrium point at
SM =
γ + ω
β
, IM =
κ(βN − γ − ω)
β(κ+ ω)
, AM =
ω(βN − γ − ω)
β(κ+ ω)
,
SE = 0, IE = 0, AE = 0
This last equilibrium is basically a degenerate case for only one ethnicity group
in the population. by symmetry the case where NM = 0 is also an equilibrium
point. It occurs at the same place as the endemic equilibrium for the original
SIAS model 4.1.
6.2.1 Ethnicity and ARF History
As we have seen earlier, how likely an individual is to develop acute rheumatic
fever also depends on whether they have had acute rheumatic fever before [1].
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SM
IM
TM
AM
SE
IE AE
TE
SA
IA TA
AASLIL
TL
βSM I
φIM ωIE
κAM
ρTM
βSEI
αIEγIE
φIE
κAE
ρTE
βSAI
λIA
ρTA
ηAA
θTA
γIM
βSLI
φIL ρTL
γIL
Figure 6.9: Flow chart for an acute rheumatic fever model including ethnicity and
rheumatic fever history.
So it makes sense that individuals with a history of acute rheumatic fever be
treated differently to those with no history of acute rheumatic fever. Also those
who have Group A streptococcus but do not develop acute rheumatic fever even
without treatment are less likely to ever develop acute rheumatic fever. It may be
useful to treat these individuals separately too. Basically we start with everyone
susceptible, in their ethnic groups and then they move into groups based on their
history in relation to acute rheumatic fever as Group A streptococcus and acute
rheumatic fever spread and develop in the population. Figure 6.9 shows this flow
of individuals.
The subscript L is used to denote those who have recovered from a Group A
streptococcus infection without treatment and without developing acute rheumatic
fever. In this model we then make the assumption that they are not susceptible
to acute rheumatic fever so will never develop it.
We have left in the possibility for individuals with a history of acute rheumatic
fever to develop it again, even after treatment. This is because of their increased
risk of developing the disease and the possibility that treatment may not always
be effective in preventing acute rheumatic fever.
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The system of differential equations for the model pictured in figure 6.9 are as
follows:
dSM
dt
= −βSM(IM + IE + IA + IL) + ρTM
dIM
dt
= βSM(IM + IE + IA + IL)− IM(φ+ γ + ω)
dTM
dt
= φIM − ρTM
dAM
dt
= ωIM − κAM
dSE
dt
= −βSE(IM + IE + IA + IL) + ρTE
dIE
dt
= βSE(IM + IE + IA + IL)− IE(γ + α + φ)
dTE
dt
= φIE − ρTE
dAE
dt
= αIE − κAE (6.9)
dSA
dt
= κ(AM + AE)− βSA(IM + IE + IA + IL) + ρTA + ηAA
dIA
dt
= βSA(IM + IE + IA + IL)− λIA
dTA
dt
= λIA − TA(ρ+ θ)
dAA
dt
= θTA − ηAA
dSL
dt
= γ(IM + IE)− βSL(IM + IE + IA + IL) + ρTL
dIL
dt
= βSL(IM + IE + IA + IL)− IL(γ + φ)
dTL
dt
= φIL − ρTL
This system has two equilibria; the disease free equilibrium at
SM + SE + SA + SL = N
IM = TM = AM = IE = TE = AE = IA = TA = AA = IL = TL = 0
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and an unrealistic endemic equilibrium that is basically the result of there being
no new entry into SM or SE. This endemic equilibrium is at
SM = SE = SL = IM = TM = AM = IE = TE = AE = IL = TL = 0
SA =
λ
β
, IA =
η(ρ+ θ)(βN − λ)
β(η(ρ+ θ) + λ(η + θ))
, TA =
λIA
ρ+ θ
, AA =
λθIA
η(ρ+ θ)
The trace for the Jacobian matrix at the disease free equilibrium is
βS − 4βI − α− η − 3γ − 2κ− λ− ω − 3φ− 4ρ− θ
Where S = SM + SE + SA + SL and I = IM + IE + IA + IL. The determinant is
0. This means the disease free equilibrium is stable from time zero if
βN < α + η + 3γ + 2κ+ λ+ ω + 3φ+ 4ρ+ θ
For the endemic equilibrium the trace is
− 4(ρ+ θ)(βN − λ)η
(ρ+ θ)η + (η + θ)λ
− α− η − 3γ − 2κ− λ− ω − 3φ− 4ρ− θ
This makes it stable when
βN < λ− (α + η + 3(γ + φ) + 2(κ+ 2ρ) + λ+ ω + θ)(η(ρ+ θ) + λ(η + θ))
4η(ρ+ θ)
This is only plausible if
λ >
(α + η + 3(γ + φ) + 2(κ+ 2ρ) + λ+ ω + θ)(η(ρ+ θ) + λ(η + θ)
4η(ρ+ θ))
as N > 1 at all times. This can only happen however, if λ is negative, so the
endemic equilibrium is not valid in this case. because of this, the diseases will
always die out for this model once I reaches a point where
βS < 4βI + α + η + 3γ + 2κ+ λ+ ω + 3φ+ 4ρ+ θ
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Figure 6.10: Plot of a numerical solution to the model seen in 6.9. Group A
streptococcus numbers are represented by the solid line, acute rheumatic fever
numbers are given by the dashed line. β = 0.00035, γ = 0.1, ω = 0.006, λ =
0.3, µ = 0.01, φ = 0.1, ρ = 0.1, κ = 0.025, η = 0.02, α = 0.003, θ = 0.001, N =
4000.
Figure 6.10 shows a plot of the Group A streptococcus and acute rheumatic fever
numbers over time for this model. For this plot, initially βN > α+ η + 3γ + 2κ+
λ + ω + 3φ + 4ρ + θ so the number of infectious individuals increases. With this
increase in infected individuals and the consequential decrease in the number of
those susceptible, we reach a point where
βS < 4βI + α + η + 3γ + 2κ+ λ+ ω + 3φ+ 4ρ+ θ
and the disease dies out. The parameters used in this plot are unrealistic, we are
just using them to show an example of what might happen using this model. More
accurate parameter values will be brought estimated in Chapter 7.
6.2.2 Age
Group A streptococcus and acute rheumatic fever are both diseases that show
increased prevalence among school aged children [12, 11, 24]. Because of this we
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should consider splitting the population into subgroups based on age. Something
else we need to note, especially when we are using vital dynamics, is that individu-
als increase in age over time. We need to allow for individuals to change subgroups
as they age. We will cover the inclusion of age and age groups in the model more
in the next section.
6.3 Using a recommended diagnosis and treat-
ment algorithm to define risk groups
The National Heart Foundation of New Zealand, together with the Cardiac Soci-
ety of Australia and New Zealand, produced the New Zealand Guideline for Sore
Throat Management in 2006. Figure 6.11 shows the flow chart based on the algo-
rithm given in the guideline, this was produced in 2007. If we base our population
groupings on the risk factors presented in this algorithm then we can treat each
risk group as it is recommended a health professional should.
To keep the model slightly simpler for now, we will be focusing on age and ethnicity
and acute rheumatic fever history. By ignoring geographic location we assume
homogenous mixing of individuals in the population. This makes the model simpler
but may affect accuracy.
6.3.1 Risk Groups
To make a model that covers age, ethnicity and acute rheumatic fever history we
need to split each of the ethnic groups into age groups. We will include a few
extra groups based on individual history of acute rheumatic fever and Group A
streptococcus. These extra groups will start out empty and grow with time as
individuals contract Group A streptococcus and develop acute rheumatic fever. In
total we have nine subgroups of individuals.
Rates of movement between groups due to ageing are fixed. Everyone increases in
age at the same rate.
Individuals under 3 years of age have a low risk of contracting Group A strepto-
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Algorithm: Guide for sore throat management 
 
 
Assess risk factors for GAS pharyngitis and/or rheumatic fever 
 
x MƗori or Pacific peoples 
x 3-45 years old 
x Lives in lower socioeconomic areas of North Island 
x Past history of acute rheumatic fever 
Medium 
Risk for GAS 
and 
rheumatic fever 
 
x Throat swab 
x Antibiotics only 
if GAS positive  
High  
Risk for GAS 
and 
rheumatic fever 
 
x Throat swab 
x Start empiric 
antibiotics 
Choose appropriate antibiotics (from tables 1 and 2)* 
Seek 
alternative 
diagnosis 
High  
Risk for GAS 
 
x Throat swab 
x Start empiric 
antibiotics 
Medium 
Risk for GAS 
 
x Throat swab 
x Antibiotics 
only if GAS 
positive 
Low 
Risk for GAS 
 
x No throat swab
x No antibiotics 
x Symptomatic 
treatment only 
Score 0-1Score 4-5
Apply Criteria:14 Score 
Temperature >38oC 1
No cough 1
Swollen, tender anterior cervical lymph nodes 1
Tonsillar swelling or exudate 1
Age 3-14 years 1
Age 15-44 years 0
Age 45+ years -1
Total Score /5
No criteria 
present 
Apply Criteria:13 
 
x Temperature >38oC 
x No cough 
x Swollen, tender anterior cervical lymph nodes
x Tonsillar swelling or exudate 
Any criteria 
present 
 
*   If patient is on benzathine penicillin IM prophylaxis for acute rheumatic fever, and is GAS positive on throat  
 swab, treat in the following way: 
x If GAS positive in the first two weeks after IM penicillin injection has been given, treat with a 10 day course of 
erythromycin (see Table 3)  
x If GAS positive in the 3rd and 4th weeks after IM penicillin injection, treat with a 10 day course of oral penicillin (see 
Table 3). 
 
Sources: 
13 Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. Med Decis Making. (1:3) pp.239-246, copyright (c) 1981 by (Sage 
Publications Inc).  Reprinted by Permission of SAGE Publications, Inc. 
14 Copyright © 2004, American Medical Association, All rights reserved.
Assess household (see next algorithm) 
Score 2-3 
0-1 risk factors2-3 risk factors 
Sore throat 
14 
Figure 6.11: The algorithim from the New Zealand Guideline for Sore Throat
Management.
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coccus or developing rheumatic fever [25]. Their mixing in the population is also
limited. To keep things simpler we will not count individuals as being ‘born’ into
the population until they turn 3. This also avoids the need to introduce a new
subgroup or loop the age groups around, by including under threes in the same
group with the over 45’s.
An individual will spend 12 years in the under 15 age group, so the rate of move-
ment out of this group is 1
12 years
or 1
4380
individuals per individual per day. Indi-
viduals spend 30 years in the 15 to 45 age group, so leave this group at a rate of
1
10950
per day. Because we are assuming a constant birth rate that is equal to the
rate of deaths, with no other sources of mortality, year groups are of equal size.
6.3.1.1 Maori and Pacific Island Groups
Maori and Pacific Islanders under 15 have the highest risk of developing acute
rheumatic fever following a Group A streptococcus infection. This age group also
has the highest risk of contracting a Group A streptococcus infection. We will
label this group of individuals with the subscript M1.
Maori and Pacific Island peoples between the ages of 15 and 45 inclusive have
less risk of contracting Group A streptococcus than their younger counterparts.
They still have a high risk of developing acute rheumatic fever after an infection
however, if it should occur. We will give this group the subscript label M2.
Maori and Pacific Island peoples over the age of 45 have even less risk of contracting
a Group A streptococcus infection. They also have a reduced risk of developing
acute rheumatic fever when compared to those in the younger age groups. This
group of individuals will be labeled with the subscript M3.
6.3.1.2 Other Ethnic Groups
Other ethnicities have a reduced risk of developing acute rheumatic fever following
a Group A streptococcus infection but their risk of this and Group A streptococcus
still varies with age.
Individuals in other ethnicities under the age of 15 have the highest risk of con-
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tracting a Group A streptococcus infection, like Maori and Pacific Islanders in the
same age group. Their risk of developing acute rheumatic fever following such an
infection, however, is lower. The individuals in this subpopulation will be labeled
with the subscript E1.
Individuals of other ethnicities between the ages of 15 and 45 have less risk of
contracting Group A streptococcus but their risk of developing acute rheumatic
fever afterwards is still similar to the younger age group. This group of individuals
will be referred to with the subscript E2.
Individuals of other ethnicities over 45 have reduced risk of contracting a Group
A streptococcus infection and a low likelihood of developing acute rheumatic fever
after the infection. They will be labelled with the subscript E3.
6.3.1.3 Rheumatic Fever History Groups
As individuals move through the compartments and develop or don’t develop acute
rheumatic fever after Group A streptococcus infections, we can introduce sub-
groups based on acute rheumatic fever history.
Individuals who develop acute rheumatic fever after a case of Group A strepto-
coccus recover into a separate group of susceptible individuals and become part
of a subgroup we will label with the subscript H. This subgroup has increased
risk of developing acute rheumatic fever if they do not receive treatment for a
Group A streptococcus infection. Their history of having had acute rheumatic
fever increases their likelihood of getting it again [27].
Individuals who recover from a Group A streptococcus infection without treat-
ment and do not develop acute rheumatic fever afterwards may have a reduced
susceptibility to developing acute rheumatic fever. We move these individuals into
a subgroup labelled with the subscript G, as they recover from their Group A
streptococcus infection. This subgroup works a bit like a buffer. It can be used to
confirm that an individual really does have a low susceptibility to acute rheumatic
fever. If individuals in this subgroup are able to recover from a Group A strepto-
coccus infection without developing acute rheumatic fever, we assume their risk is
low.
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Group GAS Rank ARF Rank GAS ARF Recovery Treatment
S −→ I I −→ A I −→ S I −→ T
M1 2 2 β ω σ r
M2 1 2 κ ω σ θ
M3 0 1 γ α λ θ
E1 2 1 β α λ θ
E2 1 1 κ α λ θ
E3 0 0 γ ϕ χ q
H 2 2 β ω σ r
G 1 1 κ α λ θ
L 1 0 κ ϕ χ q
Table 6.2: Table showing each subgroup’s risk of Group A streptococcus (GAS)
and acute rheumatic fever (ARF), and the parameters for the rates of movement
into and out of the infectious compartment.
Individuals who start in a group with low risk of Group A streptococcus or acute
rheumatic fever who contract Group A streptococcus though do not develop acute
rheumatic fever after the infection move into a subgroup with low acute rheumatic
fever risk, upon recovery. This subgroup we will label with the subscript L. In-
dividuals can only move into this subgroup from groups with the subscript G or
E3.
6.3.2 Creating the Model
We can rank each risk group on their risk of contracting Group A streptococcus
and developing acute rheumatic fever. Table 6.2 shows each subgroup and their
risk of Group A streptococcus and acute rheumatic fever given a number, 0, 1 or
2. 2 indicates a high risk and 0 a low risk, but not no risk. 1 indicates a medium
level risk.
If an individual is in the subgroup L and develops acute rheumatic fever, upon
recovery their risk of acute rheumatic fever is increased. Because of this increase
they should change subgroups. They will become part of subgroup M3 upon
recovery. This group has the same risk level for acute rheumatic fever, and because
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M3 is part of the oldest age group it cannot be aged out of. This is a modelling
convenience, individuals cannot in reality change ethnicity. Even if the individual
is not of Maori or Pacific Island ethnicity, they should be treated the same with
regards to rheumatic fever. This gives the individual time to re-establish their
low risk status or to move into the high risk subgroup H. A more detailed model
would keep these ethnic groups separate and maybe use a new subgroup fro the
from L who develop acute rheumatic fever. Because their characteristics, relative
to Group A streptococcus and acute rheumatic fever are very similar however,
combing these subgroups does not greatly affect our model.
The flow of individuals between groups and subgroups is depicted in figure 6.12.
Each sub group contains 3 or 4 compartments, so we have 29 compartments in total
for this model. Each compartment needs an equation in the system. Because of
varying rates of infection and recovery among the different subgroups, each requires
a different combination of parameters. For this particular model we are using 19
different parameters, including those for ageing between susceptible compartments.
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These equations can be seen in 6.10 below.
dSM1
dt = Mµ− βSM1I + ρTM1 − µSM1 − SM14380
dIM1
dt = βSM1(I)− IM1(ω + σ + r + µ) dTM1dt = rIM1 − (ρ+ µ)TM1
dSM2
dt =
SM1
4380 − κSM2I + ρTM2 − µSM2 − SM210950
dIM2
dt = κSM2(I)− IM2(ω + σ + θ + µ) dTM2dt = θIM2 − (ρ+ µ)TM2
dSM3
dt =
SM2
10950 − γSM3(I) + ρTM3 + φAL − µSM3
dIM3
dt = γSM3(I)− IM3(α+ λ+ θ + µ) dTM3dt = θIM3 − (ρ+ µ)TM3
dSE1
dt = Eµ− βSE1(I) + ρTE1 − µSE1 − SE14380
dIE1
dt = βSE1(I)− IE1(α+ λ+ θ + µ) dTE1dt = θIM1 − (ρ+ µ)TE1
dSE2
dt =
SE1
4380 − κSE2(I) + ρTE2 + φAL − SE210950
−µSE2
dIE2
dt = κSE2(I)− IE2(α+ λ+ θ + µ) dTE2dt = θIE2 − (ρ+ µ)TE2
dSE3
dt =
SE2
10950 − γSE3(I) + ρTE3 − µSE3
dIE3
dt = γSE3(I)− IE3(χ+ ϕ+ q + µ) dTE3dt = qIE3 − (ρ+ µ)TE3
dAH
dt = ω(IM1 + IM2 + IH)
+α(IM3 + IE1 + IE2 + IG)− (φ+ µ)AH
dSH
dt = φAH − βSHI + ρTH + σIH − µSH
dIH
dt = βSHI − IH(r + σ + ω + µ) dTHdt = rIH − (ρ+ µ)TH
dSG
dt = σ(IM1 + IM2) + λ(IM3 + IE1 + IE2)
+ρTG − κSGI − µSG
dIG
dt = κSGI − IG(α+ θ + λ+ µ) dTGdt = θIG − (ρ+ µ)TG
dSL
dt = χ(IE3 + IL) + λIG − κSLI + ρTL − µSL
dIL
dt = κSLI − (ϕ+ χ+ q + µ)IL dTLdt = qIL − (ρ+ µ)TL
dAL
dt = ϕ(IE3 + IL)− (φ+ µ)AL
(6.10)
M and E represent the proportions of Maori and Pacific Island peoples and other
ethnicities respectively.
β, κ and γ represent the different levels of susceptibility to Group A streptococcus
in each age group.
ω, α and ϕ represent the different rates of acute rheumatic fever development.
σ, λ and χ represent the different rates of recovery from Group A streptococcus,
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back to being susceptible without passing through treatment.
r, θ and q represent the different rates of treatment for Group A streptococcus in
each risk group.
The rates for each subgroup can be seen in Table 6.2.
µ is still the birth/death rate and ρ is the recovery rate following treatment for a
Group A streptococcus infection.
6.3.3 The Basic Reproduction Number
Because of the complicated structure of this model, finding equilibriums points
using the methods shown previously is difficult. We can however write an equation
for the basic reproduction number R0. We can then use this value to help us see
how the system may behave. By using the definition of R0 as the rate of infection
multiplied by how long an individual is infectious for we can calculate R0 for our
model.
Let E be the total number of individuals being infected by individuals in com-
partment IM1 per unit of time. A fraction
βSM1
E
move into the compartment IM1
as they become infectious. While individuals are in the compartment IM1 they
are causing E new infections per unit of time. The mean amount of time spent
in compartment IM1 is
1
r+ω+σ+µ
. So the portion of the basic reproduction number
due to IM1 is
RM1 = βSM1
E
× E
r + ω + σ + µ
=
βSM1
r + ω + σ + µ
We can do the same calculation for each infectious compartment and sum them
up to find R∗ as shown below.
R∗ = β
(
SM1 + SH
r + ω + σ + µ
+
SE1
θ + α + λ+ µ
)
+ κ
(
SM2
θ + ω + σ + µ
+
SE2 + SG
θ + α + λ+ µ
+
SL
q + χ+ ϕ+ µ
)
(6.11)
+ γ
(
SM3
θ + α + λ+ µ
+
SE3
q + χ+ ϕ+ µ
)
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This is the same expression as that given by the largest eigenvalue of the next
generation matrix.
R0 is R∗ at time zero. At the start of an outbreak compartments A,G and L are
empty, so
R0 = β
(
SM1
r + ω + σ + µ
+
SE1
θ + α + λ+ µ
)
+ κ
(
SM2
θ + ω + σ + µ
+
SE2
θ + α + λ+ µ
)
(6.12)
+ γ
(
SM3
θ + α + λ+ µ
+
SE3
q + χ+ ϕ+ µ
)
Chapter 7
Introducing Real Data and
Conclusions
If we are going to make a model to simulate disease in a real population, we
need to use parameter values that apply to the population and that disease. We
can use the information about acute rheumatic fever and Group A streptococcus,
seen in Chapter 3 to estimate parameters such as recovery rate with and with-
out treatment, and rates of acute rheumatic fever development. Parameters such
as population size , proportions of ethnicities and birth/death rates we can find
through Statistics New Zealand. We may have to modify some parts of our model
to fit what data may be available.
Using data on births and deaths from the Statistics New Zealand, we estimate a
value of µ. While birth rates are greater than death rates in New Zealand at the
moment, we want to estimate a value somewhere between so we can use µ for both
births and deaths. We will use µ = 0.000027 deaths per person per day = births,
based on tables from Statistics New Zealand [2] This does estimate a lifespan of
about 100 years, but this is due to the birth rate being higher that the death rate
in reality, and for the sake of simplicity in our model we are assuming no other
sources of mortality aside from natural causes . Parameters are defined on rates
of change per day. We will use a population size 0f N = 4, 000, 000.
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7.1 Ethnic Proportions
Using data from the 2006 Census, provided by Statistics New Zealand we can
estimate the proportions of Maori and Pacific peoples in each age group. Table
7.1 shows the proportions of the relevant ethnicities in each age group [2].
Ethnicity 0 to 14 15 to 44 45+ Total
European and Other 11.93% 33.05% 32.23% 79.36%
Maori and Pacific 6.2% 9.29% 3.89% 20.64%
Total 18.12% 42.34% 36.12% 100%
Table 7.1: Percentage of the total population categorised by age and ethnicity
7.2 Rates of Rheumatic Fever Development
The parameters ω, α and ϕ, are used to represent the different rates of rheumatic
fever development in each group. Several factors can affect this rate. We need
to know how long it takes acute rheumatic fever to develop after a Group A
streptococcus infection and the rate of acute rheumatic fever in that group. We
know from Chapter 3 that it takes about 3 weeks for an individual to start showing
symptoms of acute rheumatic fever following a Group A streptococcus infection.
If we treat this as 20 days we can estimate the rate of acute rheumatic fever
development for individuals susceptible to acute rheumatic fever as 0.05 per day.
α represents the rate of acute rheumatic fever for groups M3, E1, E2 and G.
From Section 3.2 we can estimate that approximately 3% of individuals in these
groups are likely to develop acute rheumatic fever following an untreated Group A
streptococcus infection. Because of this we will estimate α = 0.03× 0.05 = 0.0015
per person per day.
ω represents the rate of acute rheumatic fever development for individuals in groups
M1, M2, andH. That is Maori and Pacific peoples under 40 and individuals with a
history of acute rheumatic fever. The upper age limit of group 2 has been modified
to 40 because of data availability in age group distribution. We saw in section 3.2
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that individuals with a history of acute rheumatic fever have an increased chance of
30% to 80% of recurrence following another Group A streptococcus infection. We
also saw that Maori and Pacific peoples are 22 to 75 times more likely to develop
acute rheumatic fever than New Zealand Europeans. From this information we
could estimate 22× 3% = 66% to over 100% . But with an increased likelihood of
treatment for these groups we can reduce this a bit, to about 50%. We can then
estimate ω = 0.5× 0.05 = 0.0215 per person per day.
ϕ is the rate of acute rheumatic fever development for those with a low risk. That is
those in group E3 and group L. 0.3% is the low end of the range given in section 3.2
for the general population. This means we can estimate ϕ = 0.003×0.05 = 0.00015
per person per day.
7.3 Rates of Treatment and Recovery
Rates of treatment are something we can vary to try and reduce numbers of acute
rheumatic fever and Group A streptococcus. The part that we can’t vary is how
long it takes for individuals to receive treatment. There is a window of about 9
days within which an individual can receive treatment to prevent acute rheumatic
fever [4]. Symptoms for Group A streptococcus usually show up within 3 days
and then disappear within 4 more. We work with 5 days as it is in the middle
and gives us a nice value of 0.2 to multiply the proportions of individuals receiving
treatment by. We will start with all groups receiving treatment equally at at a
proportion of 20%. r = θ = q = 0.2× 0.2 = 0.04 per person per day.
If an individual with Group A streptococcus goes untreated, the infection can last
for 7 to 10 days [29]. After this they will either develop acute rheumatic fever or
recover. The rate of recovery if untreated is 0.1 multiplied by the proportion of
individuals likely to recover. For groups M1, M2 and H we have σ = 0.1× 0.1 =
0.01 per person per day. For groups E3 and L, we will use χ = 0.8 × 0.1 = 0.08
per person per day. For all the other groups we use λ = 0.65 × 0.1 = 0.065 per
person per day.
Treatment of Group A streptococcus reduces the duration of symptoms, and in
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our model eliminates the risk of developing rheumatic fever. The duration of
symptoms is reduced by 1 to 2 days but 10 days of treatment with antibiotics is
recommended for routine strep throat treatment [21]. So an individual will spend
10 days in the treatment compartment then recover to the relevant susceptible
compartment, implying ρ = 0.1 per person per day.
Following treatment for rheumatic fever symptoms, the attacks usually cease
within 2 month of the initial infection. This is about 60 days minus the time
spent in a Group A streptococcus compartment, which is about about 20 days if
no treatment was received. So we have φ = 0.025 per person per day.
7.4 Rates of Infection
Because of the lack of data on strep throat these values are the hardest to estimate.
We need to work backwards from numbers of rheumatic fever cases. We can use
the rates of development that we know and simpler models to try to estimate what
the overall rate of infection is, then we need to take a bit of an educated guess as
to the individual values of β, κ and γ. Using data from the New Zealand Public
Health observatory [23], we can estimate an average of 9.3 cases of acute rheumatic
fever each month from 1997 to 2010. that is 0.31 cases per day.
We also know β > κ > γ > 0, the majority of cases occur in the under 15 age
group. For now we will start with 70% of infection occurring in this age group.
20% for age group 2 and 10% for age group 3.
We know that rheumatic fever rates are not dropping, so R∗ ≥ 1. They are not
growing hugely either so the value must still be close to 1. Using equation 6.11
with our current parameters we get
R0 = β
(
0.062N
0.04 + 0.0215 + 0.01 + 0.000027
+
0.1193N
0.04 + 0.0015 + 0.065 + 0.000027
)
+ κ
(
0.0929N
0.04 + 0.0215 + 0.01 + 0.000027
+
0.3305N
0.04 + 0.0015 + 0.065 + 0.000027
)
(7.1)
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Figure 7.1: Plot of a numerical solution for the model described in 6.10 and Figure
6.12. Group A streptococcus numbers are represented by the dashed line and acute
rheumatic fever numbers by the solid line. The parameter values are defined in
the above sections.
+ γ
(
0.0389N
0.04 + 0.0015 + 0.065 + 0.000027
+
0.3223N
0.04 + 0.08 + 0.00015 + 0.000027
)
R0 = β(0.8668 + 1.1199)N + κ(1.2988 + 3.1025)N + γ(0.3652 + 2.6819)N
= 1.9868βN + 4.4013κN + 3.0471γN
R∗ = 1 is where our endemic equilibrium would be. For now we can use R0 = 1
can give us a good estimate of what β, κ and γ should be. If we use our ratios
from earlier of 70%, 20% and 10% of cases in each age group, we can estimate β, κ
and γ using, for example, βN = 0.7R0. Setting R0 = 1 we get;
β = 6.93× 10−8, κ = 1.32× 10−8 and γ = 0.73× 10−8
A plot of numerical solutions for the model given in 6.10 using these parameters is
shown in Figure 7.1 In this case there is an initial spike but then the disease dies
out. R0 = 0.9923 < 1 in this case however due to rounding errors in estimating
β, κ and γ. So the disease is dying out when we would expect it to. If we round
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Figure 7.2: Numerical solutions for the model in 6.10. Group A streptococcus
numbers a represented by the dashed line and acute rheumatic fever numbers
by the solid line. The parameter values are those defined in the above sections.
β = 7× 10−8, κ = 2× 10−8 and γ = 1× 10−8.
up to
β = 7× 10−8, κ = 2× 10−8 and γ = 1× 10−8
We get R0 = 1.1474 > 1. Figure 7.2 shows what happens with these infection rate
changes. The peak at the beginning is a lot steeper but the disease is still dying
out. Figure 7.3 shows how the reproduction number is changing over this time. R0,
is the initial reproduction number at time 0. Initially the reproduction number is
greater than 1 and the number of infected individuals increases, but as the number
of susceptible individuals gets smaller so does the effective reproduction number.
When we reach the point where R∗ < 1 the disease starts to die out. The model
with these parameters has no stable endemic equilibrium.
In this model there appears to be a threshold for R∗ to stabilise. Keeping the 70%,
20% 10% for proportion of cases in age groups, the reproduction number starts to
settle around 1 when we start with R0 at about 1.7. this is with
β = 1.123× 10−7, κ = 2.135× 10−8 and γ = 1.185× 10−8
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Figure 7.3: The effective reproduction number, given by the numerical solution to
the model in 6.10 using the same parameters as the plot in figure 7.2.
Figure 7.4 shows the effective reproduction number over time using these values.
If we play with these infection rate parameters some more and just use β = 7γ, κ =
2γ, The numbers of infected and those with rheumatic fever, start to settle out
with an R0 of about 1.68. Figure 7.5 shows a plot of this using γ = 1.4× 10−8.
We can reduce γ to about 1.345 × 10−8 before Group A streptococcus and acute
rheumatic fever start dying out instead of settling towards an equilibrium. Figure
7.6 shows a plot for this value of γ.
7.5 Matching Acute Rheumatic Fever Data
In terms of acute rheumatic fever numbers, we are aiming for them to settle at
around 12 individuals with acute rheumatic fever at any point in time. We are
currently not accounting for seasonality in this model. This is based on the data
from Statistics New Zealand with about 0.31 new cases per day and each case
taking about a month to recover. The number of individuals with acute rheumatic
fever this model, with the current parameter values is producing is still about 16
times too high. R0 = 1.52 with these infection rate values. We may need to modify
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Figure 7.4: The effective reproduction number, given by the numerical solution
to the model in 6.10 and using β = 1.123 × 10−7, κ = 2.135 × 10−8 and γ =
1.185× 10−8, with the other parameter values as defined above.
Figure 7.5: Acute rheumatic fever numbers given by the numerical solution to 6.10
with γ = 1.4× 10−8.
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Figure 7.6: The solid line shows rheumatic fever numbers, given by the numerical
solution to the model in 6.10, with γ = 1.345 × 10−8. The dashed line shows the
number of individuals infected with Group A streptococcus.
some of the other parameters to achieve the correct rate of acute rheumatic fever.
We can do this by reducing ω, α and ϕ.
Figure 7.8 shows a plot where we have acute rheumatic fever numbers settling out
to about 12 individuals. A small reduction in the rate of acute rheumatic fever
development from that shown in Figure 7.6 actually increased acute rheumatic
fever numbers. This may be because individuals spent longer in the infected com-
partment. Figure 7.7 shows what happens when make small reduction.
By reducing the acute rheumatic fever development rates we have increased the
basic reproduction number to R0 = 1.55.
Comparing these rates to the original estimates made in Sections 7.2 and 7.4, the
largest change has been made to the rate at which individuals at high risk of devel-
oping acute rheumatic fever develop the disease following a Group A streptococcus
infection, parameter ω. In our original estimate in section 7.2 we had ω ≈ 150ϕ
in our most recent estimate ω ≈ 55ϕ so this proportionality has been reduce by
almost a third. In both estimates α = 10ϕ, this has remained the same. There
has beed a large reduction in the size of ϕ between our original estimate and now,
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Figure 7.7: Rheumatic fever numbers, given by the numerical solution to 6.10 with
γ = 1.345× 10−8, ω = 0.021, α = 0.001 and ϕ = 0.0001 .
Figure 7.8: Acute rheumatic fever numbers, given by a numerical solution to the
model in 6.10, with ω = 0.000022, α = 0.000004 and ϕ = 0.0000004.
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from ϕ = 1.5× 10−4 to ϕ = 0.004× 10−4.
As far as rates of infection are concerned γ is now slightly less than twice our
original estimate, changing from γ = 0.73 × 10−8 to γ = 1.345 × 10−8. In terms
of proportion κ and β have not changed too much. In section 7.4 we originally
had κ ≈ 1.8γ and β ≈ 9.5γ, we no have κ = 2γ and β = 7γ. So the the relative
parameters are proportionally similar to what we estimated in section 7.4.
7.6 Reducing Rheumatic Fever with Treatment
of Strep Throat
In the previous plots of the model, the treatment rate has been 0.04I for all the
subgroups. Keeping all the other above parameters the same we will try now
varying treatment rates. First of all we will try focusing all the treatment on the
groups with a high risk of rheumatic fever. Let
r = 0.2, and θ = q = 0
The plot of this is shown in Figure 7.9. This focused method has actually increased
rheumatic fever numbers. The basic reproduction number in this case becomes
R0 = 2.67. So we can see just by R0 that we have made things worse.
Because any treatment plan would be implemented after we have reached equi-
librium, for a disease like rheumatic fever that has been in the population for a
while, we should try using the values of each compartment at equilibrium as our
initial values. Exclusively focusing treatment on those most a risk of rheumatic
fever still increases rheumatic fever numbers over all. The reproduction number
now becomes R∗ = 2.86 at the point in time we introduce exclusive treatment.
Maybe a better approach would be to proportionally focus treatment based on
risk, but not be exclusive. Let us try
r = 0.1, θ = 0.06 and q = 0.04
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Figure 7.9: Rheumatic fever numbers given by the numerical solution to 6.10, with
treatment rates r = 0.2 and θ = q = 0. Infection rates and other parameters are
the same as in figure 7.8.
The plot using these treatment rates is shown in figure 7.10. This proportional
method of treatment looks quite successful in reducing acute rheumatic fever num-
bers. Acute rheumatic fever has been reduced to an average of 1.4 individuals at
any one time. In this case R∗ is reduced to 0.92. Figure 7.11 shows how the re-
production number changes over time, from the introduction of this proportional
treatment.
7.7 Conclusions
Rates of acute rheumatic fever remain an issue in New Zealand. A large concern is
the increased rates for Maori and Pacific peoples. While we have not covered the
socio-economic or geographic distribution of acute rheumatic fever in this thesis,
these are also issues which require attention.
We have developed a model which accounts for the different rates of Group A
streptococcus and acute rheumatic fever among different age groups and ethnic-
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Figure 7.10: Acute rheumatic fever numbers, given by the numerical solution to
6.10, with treatment rates r = 0.1, θ = 0.6 and q = 0. All other parameters are
the same as in figure 7.8.
Figure 7.11: The reproduction number given by the numerical solution to 6.10
with treatment rates r = 0.1, θ = 0.6 and q = 0. All other parameters are the
same as in figure 7.8.
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ities. The accuracy of this model may be limited by absence of factors such as
geographic location, as mentioned above. It does however, with a bit of modifica-
tion to some parameter values, allow us to model a stable rate of acute rheumatic
fever, at values similar to that seen in the real data. Even without the manipula-
tion of the acute rheumatic fever rates, the model produced a relatively stable, if
overestimated, value for acute rheumatic fever numbers in New Zealand. It may be
that with further development of the model and the inclusion of seasonality, socioe-
conomic status and geographic location, in some combination, less modification of
parameters would be required to match what is seen in the real data.
Varying the rates of treatment in our model produced some interesting results. It
has been suggested that primary prevention of acute rheumatic fever be targeted
at high-risk individuals, rather than just the whole population. This has been
suggested as a possibly efficient means of managing the ethnic inequality [18].
Figure 7.9 shows what happened when we tried treating Group A streptococcus,
in individuals at high-risk of developing acute rheumatic fever, exclusively in our
model. The results produced here suggest that focusing treatment to the exclusion
of other groups could make acute rheumatic fever numbers worse. A higher rate of
treatment for higher risk groups did result in lower acute rheumatic fever numbers
however. As long as each risk group received some treatment for Group A strep-
tococcus infections, focusing more attention on those at higher risk of developing
acute rheumatic fever, produced desirable results.
It is possible that the increase in acute rheumatic fever numbers with exclusive
treatment, may be due to the assumption of homogeneous mixing made by our
model. An individual with a high risk of developing acute rheumatic fever, it is
assumed is just as likely to catch Group A streptococcus from some one with a low
risk of acute rheumatic fever risk as they are from someone with a very high risk.
This even possibility of infection is not necessarily true to reality. Risk factors
such as overcrowding show strong correlations with socioeconomic status and eth-
nicity. Ethnicity in turn is strongly correlated with geographic location. Factors
such as preferential mixing within ethnicity neighbourhood and social standing
may influence the impact the spread of Group A streptococcus and the impact of
treatment protocols in the population. The development of acute rheumatic fever
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may be influenced by geographic location household structure as well. Before this
type of model may be useful in management of acute rheumatic fever the inclusion
of socio-economic and geographic factors, and the use of different mixing models
must be investigated. Such further investigation is beyond the scope of this thesis
While primary prevention of acute rheumatic fever in New Zealand is currently
considered inadequate [18], this model is limited in how much we can learn with
regard to treatment protocols. From what we have seen infection between groups
may be an important factor and exclusive treatment would be unwise. Differ-
ent interaction and mixing patterns between sub-populations are something that
should be considered before a large treatment and/or prevention plan is initiated.
As the ethnic gap in rheumatic fever rate continues to grow [18], the prevention of
this disease becomes more and more important. This is a solvable problem that
deserves more attention.
Appendix A
Matlab Code
A.1 SIR and SIS Stochastic Plots
This is the code used to produce the DTMC sample paths in Sections 2.5.1 and
2.5.2. They each produce three sample paths where change in the number of
infectious individuals at each step is determined by the value of a random num-
ber. Euler’s method is used to to produce a plot of the deterministic model for
comparison.
This is the code used to produce the SIS sample paths shown in Figure 2.5.
clear
set(0,’DefaultAxesFontSize ’, 18);
set(gca ,’fontsize ’ ,18);
dt =0.01; % Time step
beta =1*dt;
b=0.1* dt;
gam =0.25* dt;
N=100;
init =2;
time =2000;
sim =3;
for k=1: sim
clear t s i
t(1)=0;
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i(1)= init;
s(1)=N-init;
j=1;
while i(j)>0 && t(j)<time
u1=rand; % uniform random number
u2=rand;
a=(( beta/N)*i(j)*s(j)+(b+gam)*i(j));
probi=(beta*s(j)/N)/( beta*s(j)/N+b+gam);
t(j+1)=t(j)+1;
if u1 > a
i(j+1)=i(j);
s(j+1)=s(j);
elseif u2 <= probi
i(j+1)=i(j)+1;
s(j+1)=s(j)-1;
else
i(j+1)=i(j)-1;
s(j+1)=s(j)+1;
end
j=j+1;
end
plot(t,i,’r-’,’LineWidth ’ ,2)
hold on
end
% Eulers method applied to the deterministic SIS model.
y(1)= init;
for k=1: time/dt
y(k+1)=y(k)+dt*(beta*(N-y(k))*y(k)/N-(b+gam)*y(k));%I
end
plot ([0:dt:time],y,’k--’,’LineWidth ’ ,2);
axis([0,time ,0 ,100]);
xlabel(’Time Steps’);
ylabel(’Number of Infectives ’);
hold off
Below is the code used to produce the SIR DTMC sample paths shown in Figure
2.6.
clear
set(0,’DefaultAxesFontSize ’, 18);
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set(gca ,’fontsize ’ ,18);
dt =0.01;
beta =1*dt;
b=0*dt;
gam =0.25* dt;
N=100;
init =2;
time =2000;
sim =3;
for k=1: sim
clear t s i
t(1)=0;
i(1)= init;
r(1)=0;
s(1)=N-init;
j=1;
while i(j)>0 && t(j)<time
u1=rand; % uniform random number
u2=rand; % uniform random number
a=(beta/N)*i(j)*s(j)+gam*i(j)+b*(N-s(j));
probi=(beta*s(j)*i(j)/N)/a;
t(j+1)=t(j)+1;
if u1 > a
i(j+1)=i(j);
s(j+1)=s(j);
r(j+1)=r(j);
elseif u2 <= probi
i(j+1)=i(j)+1;
s(j+1)=s(j)-1;
r(j+1)=r(j);
else
i(j+1)=i(j)-1;
s(j+1)=s(j);
r(j+1)=r(j)+1;
end
j=j+1;
end
plot(t,i,’r-’,’LineWidth ’ ,2)
hold on
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end
% Euler ’s method applied to the deterministic SIR model.
y(1)= init; %y=i
x(1)=0; %x=r
for k=1: time/dt
x(k+1)=x(k)+dt*(gam*y(k)-b*x(k));%R
y(k+1)=y(k)+dt*(( beta*y(k)*(N-(x(k)+y(k))))/N-(b+gam)*y(k));%I
end
plot ([0:dt:time],y,’k--’,’LineWidth ’ ,2);
axis([0,time ,0 ,60]);
xlabel(’Time Steps’);
ylabel(’Number of Infectives ’);
hold off
The code below was used to produce the three sample paths shown in figure 2.7.
The time it takes for a change of stare to occur is determined by t(j + 1) =
t(j)− log(u1)/a. where u1 is a random number.
clear
set(0,’DefaultAxesFontSize ’, 18);
set(gca ,’fontsize ’ ,18);
beta =1;
b=0.1;
gam =0.25;
N=100;
init =2;
dt =0.01;
time =20;
sim =3;
for k=1: sim
clear t s i
t(1)=0;
i(1)= init;
s(1)=N-init;
j=1;
while i(j)>0 & t(j)<time
u1=rand; % uniform random number
u2=rand; % uniform random number
a=(beta/N)*i(j)*s(j)+(b+gam)*i(j);
probi=(beta*s(j)/N)/( beta*s(j)/N+b+gam);
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t(j+1)=t(j)-log(u1)/a;
if u2 <= probi
i(j+1)=i(j)+1;
s(j+1)=s(j)-1;
else
i(j+1)=i(j)-1;
s(j+1)=s(j)+1;
end
j=j+1;
end
plot(t,i,’r-’,’LineWidth ’ ,2)
hold on
end
% Euler ’??s method applied to the deterministic SIS model.
y(1)= init;
for k=1: time/dt
y(k+1)=y(k)+dt*(beta*(N-y(k))*y(k)/N-(b+gam)*y(k));
end
plot ([0:dt:time],y,’k--’,’LineWidth ’ ,2);
axis([0,time ,0 ,100]);
xlabel(’Time’);
ylabel(’Number of Infectives ’);
hold off
A.2 SIAS Plots
This section contains the code used to produce the deterministic and stochastic
plots seen in Chapter 4.
A.2.1 Deterministic Plot
The bit of code below defines the function we are trying to solve.
function dy=sias(t,y)
dy=zeros (3 ,1);
bta =0.00001;
gam =0.25;
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kap =0.1;
om=0.1;
dy(1) = -bta*y(1)*y(2)+ gam*y(2)+ kap*y(3);%S
dy(2) = bta*y(1)*y(2) -(gam+om)*y(2);%I
dy(3) = om*y(2) - kap*y(3);%A
This next bit of code uses the Runge-Kutta method to solve the system, given
parameter and initial values. It then produces a plot of the solution, as seen in
Figure 4.2.
clear
init =1;
bta =0.01;
gam =0.4;
om =0.02;
kap =0.8;
N=100;
time =2000;
options = odeset(’RelTol ’,1e-4,’AbsTol ’,1e-4);
[T,Y] = ode45(@ARFHIST ,[0 time],[N-init , init , 0],options );
R= bta*Y(: ,1)/( gam+om+mu) + bta*Y(: ,4)/( chi+sig+mu);
plot(T,Y(:,3),’-’,T,Y(:,2),’--’);
%plot(T,R,’.’);
A.2.2 Stochastic Plots
This is the code used to produce the stochastic plots for the basic SIAS model.
Both programmes produce three sample paths and plot them along with the de-
terministic model.
The code used to produce the DTMC sample paths in the Figure 4.5 is shown
below.
clear
set(0,’DefaultAxesFontSize ’, 18);
set(gca ,’fontsize ’ ,18);
dt =0.01;
beta =1*dt;
b=0*dt;
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gam =0.5*dt;
om=0.2* dt;
kap =0.8*dt;
N=100;
init =2;
time =2000;
sim =3;
for k=1: sim
clear t s i r
i=zeros(time +1);
r=zeros(time +1);
s=zeros(time +1);
j=linspace(0,time ,time +1);
t=zeros(time +1);
m=zeros(time +1);
t(1)=0;
i(1)= init;
r(1)=0;
s(1)=1 - init;
m(1)=0;
j=1;
while i(j)>0 && t(j)<time
u1=rand;
u2=rand;
a=(beta/N)*i(j)*s(j)+(gam+om+b)*i(j)+r(j)*(kap+b);
probi=(beta*s(j)*i(j)/N)/a;
probr=(om*i(j))/a;
probs=(b+gam)*i(j)/a;
t(j+1)=t(j)+1;
if u1 > a
i(j+1)=i(j);
s(j+1)=s(j);
r(j+1)=r(j);
elseif u2 <= probi
i(j+1)=i(j)+1;
s(j+1)=s(j)-1;
r(j+1)=r(j);
elseif u2 <= (probi+probr)
i(j+1)=i(j)-1;
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s(j+1)=s(j);
r(j+1)=r(j)+1;
elseif u2 <= (probi+probr+probs)
i(j+1)=i(j)-1;
s(j+1)=s(j)+1;
r(j+1)=r(j);
else
i(j+1)=i(j);
s(j+1)=s(j)+1;
r(j+1)=r(j)-1;
end
I(j+1)=i(j+1)/N;
A(j+1)=r(j+1)/N;
j=j+1;
end
%plot(t,A,’g-’,’LineWidth ’,2)
plot(t,I,’r-’,’LineWidth ’ ,2)
hold on
end
% Euler ??s method
y(1)= init;
x(1)=0;
for k=1: time/dt
x(k+1)=x(k)+dt*(om*y(k)-(kap+b)*x(k));%A
y(k+1)=y(k)+dt*(beta*(1-y(k)-x(k))*y(k)-(b+gam+om)*y(k));%I
end
plot ([0:dt:time],x,’b--’,’LineWidth ’ ,2);
plot ([0:dt:time],y,’k--’,’LineWidth ’ ,2);
axis([0,time ,0 ,1]);
xlabel(’Time’);
ylabel(’Number of Infectives ’);
hold off
The CTMC sample paths seen in Figure 4.6 were produced using the following
code.
clear
set(0,’DefaultAxesFontSize ’, 18);
set(gca ,’fontsize ’ ,18);
beta =0.02;
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b=0.0;
gam =0.5;
om=0.2;
kap =0.8;
N=100;
init =2;
time =20;
sim =2;
for k=1: sim
clear t s i r
t(1)=0;
i(1)= init;
a(1)=0;
s(1)=N-init;
c(1)=0;
m(1)=0;
p(1)=0;
j=1;
while (i(j)+a(j))>0 && t(j) <time
u1=rand; % uniform random number
u2=rand; % uniform random number
r=(beta)*i(j)*s(j)+(gam+om)*i(j)+kap*a(j);
probi=(beta*s(j)*i(j))/r;
proba=om*i(j)/r;
probis=gam*i(j)/r;
probas=kap*a(j);
c(j)=-(log(u1))/r;
t(j+1)=t(j)+c(j);
if u2 <= probi
i(j+1)=i(j)+1;
s(j+1)=s(j)-1;
a(j+1)=a(j);
elseif u2 <= (probi+proba)
i(j+1)=i(j)-1;
s(j+1)=s(j);
a(j+1)=a(j)+1;
elseif u2 <= (probi + proba + probis)
i(j+1)=i(j)-1;
s(j+1)=s(j)+1;
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a(j+1)=a(j);
elseif u2 <= (probi + proba + probis + probas)
i(j+1)=i(j);
s(j+1)=s(j)+1;
a(j+1)=a(j)-1;
else
i(j+1)=i(j);
s(j+1)=s(j);
a(j+1)=a(j);
end
j=j+1;
end
plot(t,i,’r-’,’LineWidth ’ ,2)
hold on
plot(t,a,’g-’,’LineWidth ’ ,2)
end
% Euler
dt =0.01;
y(1)= init;
x(1)=0;
for k=1: time/dt
x(k+1)=x(k)+dt*(om*y(k)-(kap+b)*x(k));
y(k+1)=y(k)+dt*(beta*(N-y(k)-x(k))*y(k)-(b+gam+om)*y(k));
end
plot ([0:dt:time],x,’b--’,’LineWidth ’ ,2);
plot ([0:dt:time],y,’k--’,’LineWidth ’ ,2);
axis([0,time ,0 ,80]);
xlabel(’Time’);
ylabel(’Number of Infectives ’);
hold off
A.2.3 SIAS with Vital Dynamics
This is the code that was used to produce the two sample paths seen in Figure
5.2. In this case we have used ode45 and the Runge-Kutta method to plot the
deterministic model.
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clear
set(0,’DefaultAxesFontSize ’, 18);
set(gca ,’fontsize ’ ,18);
beta =0.001;
mu =0.01;
gam =0.1;
om =0.03;
rho =0.1;
phi =0.1;
eta =0.025;
lam =0.09;
sig =0.8;
N=400;
init =1;
time =1000;
sim =2;
for k=1: sim
clear t s i r m a ta sa ia c
t(1)=0;
c(1)=0;
s(1)=N-2* init;
i(1)= init;
m(1)=0;
a(1)=0;
ta (1)=0;
sa (1)=0;
ia(1)= init;
j=1;
while i(j)>0 && t(j)<time
u1=rand; % uniform random number
u2=rand; % uniform random number
r=(beta/N)*(i(j)+ia(j))*(s(j)+sa(j))
+(gam+om+phi+mu)*i(j)+( rho+mu)*m(j)
+(eta+mu)*a(j)+( lam+mu)*ta(j)
+(sig+mu)*ia(j)+mu*sa(j);
probs=(gam*i(j)+mu*i(j))/r;
probi=(beta/N)*(i(j)+ia(j))*s(j)/r;
probm=phi*i(j)/r;
proba=om*i(j)/r;
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probas=mu*a(j)/r;
probsm =(rho+mu)*m(j)/r;
probta=sig*a(j)/r;
probtas=mu*ta(j)/r;
probsa =(eta)*a(j)/r;
probtasa=lam*ta(j)/r;
probsas=mu*sa(j)/r;
probia =(beta/N)*(i(j)+ia(j))*sa(j)/r;
probias=mu*ia(j)/r;
c(j)=-(log(u1))/r;
t(j+1)=t(j)+c(j);
if u2 <= probs
s(j+1)=s(j)+1;
i(j+1)=i(j)-1;
m(j+1)=m(j);
a(j+1)=a(j);
ta(j+1)=ta(j);
sa(j+1)=sa(j);
ia(j+1)=ia(j);
elseif u2 <= (probs+probi)
s(j+1)=s(j)-1;
i(j+1)=i(j)+1;
m(j+1)=m(j);
a(j+1)=a(j);
ta(j+1)=ta(j);
sa(j+1)=sa(j);
ia(j+1)=ia(j);
elseif u2 <= (probs+probi+probm)
s(j+1)=s(j);
i(j+1)=i(j)-1;
m(j+1)=m(j)+1;
a(j+1)=a(j);
ta(j+1)=ta(j);
sa(j+1)=sa(j);
ia(j+1)=ia(j);
elseif u2 <= (probs+probi+probm+proba)
s(j+1)=s(j);
i(j+1)=i(j)-1;
m(j+1)=m(j);
APPENDIX A. MATLAB CODE 130
a(j+1)=a(j)+1;
ta(j+1)=ta(j);
sa(j+1)=sa(j);
ia(j+1)=ia(j);
elseif u2 <= (probs+probi+probm+proba+probsm)
s(j+1)=s(j)+1;
i(j+1)=i(j);
m(j+1)=m(j)-1;
a(j+1)=a(j);
ta(j+1)=ta(j);
sa(j+1)=sa(j);
ia(j+1)=ia(j);
elseif u2 <= (probs+probi+probm+proba+probsm+probta)
s(j+1)=s(j);
i(j+1)=i(j);
m(j+1)=m(j);
a(j+1)=a(j)-1;
ta(j+1)=ta(j)+1;
sa(j+1)=sa(j);
ia(j+1)=ia(j);
elseif u2 <= (probs+probi+probm+proba+probsm
+probta+probtas)
s(j+1)=s(j)+1;
i(j+1)=i(j);
m(j+1)=m(j);
a(j+1)=a(j);
ta(j+1)=ta(j)-1;
sa(j+1)=sa(j);
ia(j+1)=ia(j);
elseif u2 <= (probs+probi+probm+proba+probsm
+probta+probtas+probsa)
s(j+1)=s(j);
i(j+1)=i(j);
m(j+1)=m(j);
a(j+1)=a(j)-1;
ta(j+1)=ta(j);
sa(j+1)=sa(j)+1;
ia(j+1)=ia(j);
elseif u2 <= (probs+probi+probm+proba+probsm
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+probta+probsa+probtas+probsas)
s(j+1)=s(j)+1;
i(j+1)=i(j);
m(j+1)=m(j);
a(j+1)=a(j);
ta(j+1)=ta(j);
sa(j+1)=sa(j)-1;
ia(j+1)=ia(j);
elseif u2 <= (probs+probi+probm+proba+probsm+probta
+probsa+probtas+probsas+probia)
s(j+1)=s(j);
i(j+1)=i(j);
m(j+1)=m(j);
a(j+1)=a(j);
ta(j+1)=ta(j);
sa(j+1)=sa(j)-1;
ia(j+1)=ia(j)+1;
elseif u2 <= (probs+probi+probm+proba+probsm+probta
+probsa+probtas+probsas+probia+probas)
s(j+1)=s(j)+1;
i(j+1)=i(j);
m(j+1)=m(j);
a(j+1)=a(j)-1;
ta(j+1)=ta(j);
sa(j+1)=sa(j);
ia(j+1)=ia(j);
elseif u2 <= (probs+probi+probm+proba+probsm
+probta+probsa+probtas+probsas
+probia+probas+probtasa)
s(j+1)=s(j);
i(j+1)=i(j);
m(j+1)=m(j);
a(j+1)=a(j);
ta(j+1)=ta(j)-1;
sa(j+1)=sa(j)+1;
ia(j+1)=ia(j);
else
s(j+1)=s(j)+1;
i(j+1)=i(j);
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m(j+1)=m(j);
a(j+1)=a(j);
ta(j+1)=ta(j);
sa(j+1)=sa(j);
ia(j+1)=ia(j)-1;
end
j=j+1;
end
plot(t,a,’r-’,’LineWidth ’ ,2)
plot(t,i+ia ,’b-.’,’LineWidth ’ ,2)
hold on
end
options = odeset(’RelTol ’,1e-4,’AbsTol ’,1e-4);
[T,Y] = ode45(@vitSIATSDEs ,[0 time],
[N-init init 0 0 0 init 0 4.33] , options );
R= (beta*Y(: ,1))/((mu+phi+gam+om)) + (beta*Y(: ,5))/((mu+sig));
plot(T,Y(:,2)+Y(:,6),’-’,T,Y(:,4),’-.’);
plot ([0:dt:time],A,’k--’,’LineWidth ’ ,2);
plot ([0:dt:time],I+Ia ,’g.’,’LineWidth ’ ,2);
axis([0,time ,0 ,100]);
xlabel(’Time’);
ylabel(’Number of Individuals ’);
hold off
The code used to input the deterministic model for solving is given below.
function dy = vitSIATSDEs(t,y)
dy=zeros (8 ,1);
bta =0.0009;
gam =0.1;
om =0.03;
lam =0.09;
mu =0.01;
phi =0.1;
rho =0.1;
eta =0.025;
sig =0.8;
N=400;
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dy(1)= mu*N-bta*y(1)*(y(2)+y(6))+ gam*y(2)+ rho*y(3)-mu*y(1);
dy(2)= bta*y(1)*(y(2)+y(6)) -( gam+phi+om+mu)*y(2);
dy(3)= phi*y(2)-(rho+mu)*y(3);
dy(4)=om*y(3)-(eta+mu)*y(4);
dy(5)= eta*y(4) +lam*y(7)-bta*y(5)*(y(2)+y(6))-mu*y(5);
dy(6)= bta*y(5)*(y(2)+y(6)) -( sig+mu)*y(6);
dy(7)= sig*y(6)-(lam+mu)*y(7);
A.3 New Zealand Specific Model
This is the code that was used to produce the plots in Chapter 7. The values of the
parameters were varied from plot to plot. ode45 uses the Runge-Kutta to solve
the function labeled MPIage, defined below. R was used to plot the reproduction
number.
clear
init =1;
%bta =0.000000105;
%kap =0.00000002;
gam =0.00000001345;
bta =7* gam;
kap =2* gam;
om =0.000022;
alp =0.000004;
vp =0.0000004;
sig =0.01;
lam =0.065;
chi =0.08;
r=0.1;
the =0.06;
q=0.04;
mu =0.000027;
phi =0.025;
rho =0.1;
time =20000;
N=4000000;
options = odeset(’RelTol ’,1e-4,’AbsTol ’,1e-4);
[T,Y] = ode45(@MPIAge ,[0 time ] ,[0.5181*10^5 6.171*10^4 9871 9428
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3208 100 3770 1283 40 11.7 1.737*10^4 2720 403.6 1235 55 3.6
494 22 1.4 1.039 685 124.7 49.88 7.641*10^4 1552 621 3.656*10^6
6.501*10^4 2.6*10^4] , options );
R= bta*((Y(: ,1)+Y(: ,21))/(r+om+sig+mu)+Y(: ,11)/( the+alp+lam+mu))+
kap*(Y(: ,2)/( the+om+sig+mu)+(Y(: ,12)+Y(: ,24))/( the+alp+lam+mu)+
Y(: ,27)/(q+chi+vp+mu))+gam*(Y(: ,3)/( the+alp+lam+mu)+Y(: ,13)/(q+
chi+vp+mu)); % Reproduction number
%plot(T,Y(: ,10)+Y(:,20),’-’,T,Y(: ,4)+Y(: ,5)+Y(: ,6)+Y(: ,14)+Y(: ,15)
+Y(: ,16)+Y(: ,22)+Y(: ,25)+Y(:,28),’-.’);
%plot(T,Y(:,29),’-’);
plot(T,R,’.’);
The code below was defines the model we are wanting to plot
function dy = MPIage(t,y)
dy=zeros (29 ,1);
gam =0.00000001345;
bta =7* gam;%beta
kap =2* gam;
om =0.000022;
alp =0.000004;
vp =0.0000004;
sig =0.01;
lam =0.065;
chi =0.08;
r=0.1;
the =0.06;
q=0.04;
mu =0.000027;
phi =0.025;
rho =0.1;
M=0.215;
E=0.785;
N=4000000;
dy(1) = mu*M*N - bta*y(1)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) + rho*y(7) - mu*y(1) - y(1)/4380;%Sm1
dy(2) = y(1)/4380 - kap*y(2)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) + rho*y(8) - mu*y(2) - y(2)/9125;%Sm2
dy(3) = y(2)/9125 - gam*y(3)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) + rho*y(9) + phi*y(20) - mu*y(3);%Sm3
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dy(4) = bta*y(1)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) - y(4)*(r+om+sig+mu);%Im1
dy(5)= kap*y(2)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) - y(5)*( the+om+sig+mu);%Im2
dy(6)= gam*y(3)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) - y(6)*( the+alp+lam+mu);%Im3
dy(7) = r*y(4) - (rho+mu)*y(7);%Tm1
dy(8) = the*y(5) - (rho+mu)*y(8);%Tm2
dy(9) = the*y(6) - y(9)*( rho+mu);%Tm3
dy(10) = om*(y(4)+y(5)+y(22)) + alp*(y(6)+y(14)+y(15)+y(25))
- (phi+mu)*y(10);%Ah
dy(11) = mu*E*N - bta*y(11)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) + rho*y(17) - mu*y(11) - y(11)/4380;%So1
dy(12) = y(11)/4380 - kap*y(12)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) + rho*y(18) - mu*y(12) - y(12)/9125;%So2
dy(13) = y(12)/9125 - gam*y(13)*(y(4)+y(5)+y(6)+y(14)+y(15)
+y(16)+y(22)+y(25)+y(28)) + rho*y(19) - mu*y(13);%So3
dy(14) = bta*y(11)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) - y(14)*( the+alp+lam+mu);%Io1
dy(15) = kap*y(12)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) - y(15)*( the+alp+lam+mu);%Io2
dy(16) = gam*y(13)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) - y(16)*(q+vp+chi+mu);%Io3
dy(17) = the*y(14) - (rho+mu)*y(17);%To1
dy(18) = the*y(15) - (rho+mu)*y(18);%To1
dy(19) = q*y(16) - (rho+mu)*y(19);%To3
dy(20) = vp*(y(19)+y(28)) - (phi+mu)*y(20);%Al
dy(21) = phi*y(20) + sig*y(22) + rho*y(23) - bta*y(21)*(y(4)
+y(5)+y(6)+y(14)+y(15)+y(16)+y(22)+y(25)+y(28)) - mu*y(21);%Sh
dy(22) = bta*y(21)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) -y(22)*(r+om+sig+mu);%Ih
dy(23) = r*y(22) - (rho+mu)*y(23);%Th
dy(24) = lam*(y(6)+y(14)+y(15))+ sig*(y(4)+y(5))
- kap*y(24)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)+y(22)+y(25)+y(28))
+ rho*y(26)-mu*y(24);%Sg
dy(25) = kap*y(24)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) - y(25)*( the+alp+lam+mu);%Ig
dy(26) = the*y(25) - (rho+mu)*y(26);%Tg
dy(27) = chi*(y(16)+y(28)) + lam*y(25) - kap*y(27)*(y(4)+y(5)+y(6)
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+y(14)+y(15)+y(16)+y(22)+y(25)+y(28))+ rho*y(29)-mu*y(27);%Sl
dy(28) = kap*y(27)*(y(4)+y(5)+y(6)+y(14)+y(15)+y(16)
+y(22)+y(25)+y(28)) - y(28)*( chi+q+vp+mu);%Il
dy(29) = q*y(28) - (rho+mu)*y(29);%Tl
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